Fentora (Fentanyl Buccal)

Size: px
Start display at page:

Download "Fentora (Fentanyl Buccal)"

Transcription

1 Texas Prior Authorization Program Clinical Edit Criteria Drug/Drug Class Fentora (Fentanyl Buccal) Clinical Edit Information Included in this Document Fentora 100mcg Drugs requiring prior authorization: the list of drugs requiring prior authorization for this clinical edit Prior authorization criteria logic: a description of how the prior authorization request will be evaluated against the clinical edit criteria rules Logic diagram: a visual depiction of the clinical edit criteria logic Supporting tables: a collection of information associated with the steps within the criteria (diagnosis codes, procedure codes, and therapy codes); provided when applicable References: clinical publications and sources relevant to this clinical edit Fentora 200mcg Drugs requiring prior authorization: the list of drugs requiring prior authorization for this clinical edit Prior authorization criteria logic: a description of how the prior authorization request will be evaluated against the clinical edit criteria rules Logic diagram: a visual depiction of the clinical edit criteria logic Supporting tables: a collection of information associated with the steps within the criteria (diagnosis codes, procedure codes, and therapy codes); provided when applicable References: clinical publications and sources relevant to this clinical edit April 3, 2015 Copyright Health Information Designs, LLC 1

2 Fentora (Fentanyl Buccal) Fentora 300mcg and 400mcg Drugs requiring prior authorization: the list of drugs requiring prior authorization for this clinical edit Prior authorization criteria logic: a description of how the prior authorization request will be evaluated against the clinical edit criteria rules Logic diagram: a visual depiction of the clinical edit criteria logic Supporting tables: a collection of information associated with the steps within the criteria (diagnosis codes, procedure codes, and therapy codes); provided when applicable References: clinical publications and sources relevant to this clinical edit Fentora 600mcg and 800mcg Drugs requiring prior authorization: the list of drugs requiring prior authorization for this clinical edit Prior authorization criteria logic: a description of how the prior authorization request will be evaluated against the clinical edit criteria rules Logic diagram: a visual depiction of the clinical edit criteria logic Supporting tables: a collection of information associated with the steps within the criteria (diagnosis codes, procedure codes, and therapy codes); provided when applicable References: clinical publications and sources relevant to this clinical edit Note: Click the hyperlink to navigate directly to that section. Revision Notes Updated to include ICD-10s. April 3, 2015 Copyright Health Information Designs, LLC 2

3 Fentora (Fentanyl Buccal) 100mcg Drugs Requiring Prior Authorization Drugs Requiring Prior Authorization Label Name GCN FENTORA 100 MCG BUCCAL TABLET April 3, 2015 Copyright Health Information Designs, LLC 3

4 1. Is the client greater than or equal to ( ) 18 years of age? [ ] Yes (Go to #2) [ ] No (Deny) Fentora (Fentanyl Buccal) 100mcg Clinical Edit Criteria Logic 2. Does the client have a diagnosis of malignant cancer in the last 2 years? [ ] Yes (Go to #4) [ ] No (Go to #3) 3. Does the client have a history of an antineoplastic agent in the last 365 days? [ ] Yes (Go to #4) [ ] No (Deny) 4. Does the client have a history of opioid tolerance with defined oral morphine, transdermal fentanyl, oxycodone, hydromorphone, OR oxymorphone therapy in the last 30 days? [ ] Yes (Go to #5) [ ] No (Deny) 5. Does the client have a history of opioid therapy in the last 14 days? [ ] Yes (Go to #6) [ ] No (Deny) 6. Does the client have a history of MAOI therapy in the last 30 days? [ ] Yes (Deny) [ ] No (Go to #7) 7. Is the request for less than or equal to ( ) 4 units/day? [ ] Yes (Approve 365 days) [ ] No (Deny) April 3, 2015 Copyright Health Information Designs, LLC 4

5 Fentora (Fentanyl Buccal) 100mcg Clinical Edit Criteria Logic Diagram Step 1 Step 2 Step 4 Is the client greater than or equal to ( ) 18 years of age? No Yes Does the client have a diagnosis of malignant cancer in the last 2 years? No Yes Yes Does the client have a history of opioid tolerance with defined oral morphine, transdermal fentanyl, oxycodone, hydromorphone, OR oxymorphone therapy in the last 30 days? No Deny Request Step 3 Deny Request No Does the client have a history of an antineoplastic agent in the last 365 days? Yes Step 6 Step 5 Deny Request Yes Does the client have a history of MAOI therapy in the last 30 days? Yes Does the client have a history of opioid therapy in the last 14 days? No Deny Request No Step 7 Is the dose per day less than or equal to ( ) 4 units? No Deny Request Yes Approve Request (365 days) April 3, 2015 Copyright Health Information Designs, LLC 5

6 Fentora (Fentanyl Buccal) 100mcg Clinical Edit Criteria Supporting Tables ICD-9 Code Description 1400 MAL NEO UPPER VERMILION 1401 MAL NEO LOWER VERMILION 1403 MAL NEO UPPER LIP, INNER 1404 MAL NEO LOWER LIP, INNER 1405 MAL NEO LIP, INNER NOS 1406 MAL NEO LIP, COMMISSURE 1408 MAL NEO LIP NEC 1409 MAL NEO LIP/VERMIL NOS 1410 MAL NEO TONGUE BASE 1411 MAL NEO DORSAL TONGUE 1412 MAL NEO TIP/LAT TONGUE 1413 MAL NEO VENTRAL TONGUE 1414 MAL NEO ANT 2/3 TONGUE 1415 MAL NEO TONGUE JUNCTION 1416 MAL NEO LINGUAL TONSIL 1418 MALIG NEO TONGUE NEC 1419 MALIG NEO TONGUE NOS 1420 MALIG NEO PAROTID 1421 MALIG NEO SUBMANDIBULAR 1422 MALIG NEO SUBLINGUAL 1428 MAL NEO MAJ SALIVARY NEC 1429 MAL NEO SALIVARY NOS 1430 MALIG NEO UPPER GUM 1431 MALIG NEO LOWER GUM 1438 MALIG NEO GUM NEC 1439 MALIG NEO GUM NOS 1440 MAL NEO ANT FLOOR MOUTH 1441 MAL NEO LAT FLOOR MOUTH 1448 MAL NEO MOUTH FLOOR NEC 1449 MAL NEO MOUTH FLOOR NOS 1450 MAL NEO CHEEK MUCOSA 1451 MAL NEO MOUTH VESTIBULE 1452 MALIG NEO HARD PALATE April 3, 2015 Copyright Health Information Designs, LLC 6

7 1453 MALIG NEO SOFT PALATE 1454 MALIGNANT NEOPLASM UVULA 1455 MALIGNANT NEO PALATE NOS 1456 MALIG NEO RETROMOLAR 1458 MALIG NEOPLASM MOUTH NEC 1459 MALIG NEOPLASM MOUTH NOS 1460 MALIGNANT NEOPL TONSIL 1461 MAL NEO TONSILLAR FOSSA 1462 MAL NEO TONSIL PILLARS 1463 MALIGN NEOPL VALLECULA 1464 MAL NEO ANT EPIGLOTTIS 1465 MAL NEO EPIGLOTTIS JUNCT 1466 MAL NEO LAT OROPHARYNX 1467 MAL NEO POST OROPHARYNX 1468 MAL NEO OROPHARYNX NEC 1469 MALIG NEO OROPHARYNX NOS 1470 MAL NEO SUPER NASOPHARYN 1471 MAL NEO POST NASOPHARYNX 1472 MAL NEO LAT NASOPHARYNX 1473 MAL NEO ANT NASOPHARYNX 1478 MAL NEO NASOPHARYNX NEC 1479 MAL NEO NASOPHARYNX NOS 1480 MAL NEO POSTCRICOID 1481 MAL NEO PYRIFORM SINUS 1482 MAL NEO ARYEPIGLOTT FOLD 1483 MAL NEO POST HYPOPHARYNX 1488 MAL NEO HYPOPHARYNX NEC 1489 MAL NEO HYPOPHARYNX NOS 1490 MAL NEO PHARYNX NOS 1491 MAL NEO WALDEYER'S RING 1498 MAL NEO ORAL/PHARYNX NEC 1499 MAL NEO OROPHRYN ILL-DEF 1500 MAL NEO CERVICAL ESOPHAG 1501 MAL NEO THORACIC ESOPHAG 1502 MAL NEO ABDOMIN ESOPHAG 1503 MAL NEO UPPER 3RD ESOPH 1504 MAL NEO MIDDLE 3RD ESOPH 1505 MAL NEO LOWER 3RD ESOPH 1508 MAL NEO ESOPHAGUS NEC 1509 MAL NEO ESOPHAGUS NOS April 3, 2015 Copyright Health Information Designs, LLC 7

8 1510 MAL NEO STOMACH CARDIA 1511 MALIGNANT NEO PYLORUS 1512 MAL NEO PYLORIC ANTRUM 1513 MAL NEO STOMACH FUNDUS 1514 MAL NEO STOMACH BODY 1515 MAL NEO STOM LESSER CURV 1516 MAL NEO STOM GREAT CURV 1518 MALIG NEOPL STOMACH NEC 1519 MALIG NEOPL STOMACH NOS 1520 MALIGNANT NEOPL DUODENUM 1521 MALIGNANT NEOPL JEJUNUM 1522 MALIGNANT NEOPLASM ILEUM 1523 MAL NEO MECKEL'S DIVERT 1528 MAL NEO SMALL BOWEL NEC 1529 MAL NEO SMALL BOWEL NOS 1530 MAL NEO HEPATIC FLEXURE 1531 MAL NEO TRANSVERSE COLON 1532 MAL NEO DESCEND COLON 1533 MAL NEO SIGMOID COLON 1534 MALIGNANT NEOPLASM CECUM 1535 MALIGNANT NEO APPENDIX 1536 MALIG NEO ASCEND COLON 1537 MAL NEO SPLENIC FLEXURE 1538 MALIGNANT NEO COLON NEC 1539 MALIGNANT NEO COLON NOS 1540 MAL NEO RECTOSIGMOID JCT 1541 MALIGNANT NEOPL RECTUM 1542 MALIG NEOPL ANAL CANAL 1543 MALIGNANT NEO ANUS NOS 1548 MAL NEO RECTUM/ANUS NEC 1550 MAL NEO LIVER, PRIMARY 1551 MAL NEO INTRAHEPAT DUCTS 1552 MALIGNANT NEO LIVER NOS 1560 MALIG NEO GALLBLADDER 1561 MAL NEO EXTRAHEPAT DUCTS 1562 MAL NEO AMPULLA OF VATER 1568 MALIG NEO BILIARY NEC 1569 MALIG NEO BILIARY NOS 1570 MAL NEO PANCREAS HEAD 1571 MAL NEO PANCREAS BODY April 3, 2015 Copyright Health Information Designs, LLC 8

9 1572 MAL NEO PANCREAS TAIL 1573 MAL NEO PANCREATIC DUCT 1574 MAL NEO ISLET LANGERHANS 1578 MALIG NEO PANCREAS NEC 1579 MALIG NEO PANCREAS NOS 1580 MAL NEO RETROPERITONEUM 1588 MAL NEO PERITONEUM NEC 1589 MAL NEO PERITONEUM NOS 1590 MALIG NEO INTESTINE NOS 1591 MALIGNANT NEO SPLEEN NEC 1598 MAL NEO GI/INTRA-ABD NEC 1599 MAL NEO GI TRACT ILL-DEF 1600 MAL NEO NASAL CAVITIES 1601 MALIG NEO MIDDLE EAR 1602 MAL NEO MAXILLARY SINUS 1603 MAL NEO ETHMOIDAL SINUS 1604 MALIG NEO FRONTAL SINUS 1605 MAL NEO SPHENOID SINUS 1608 MAL NEO ACCESS SINUS NEC 1609 MAL NEO ACCESS SINUS NOS 1610 MALIGNANT NEO GLOTTIS 1611 MALIG NEO SUPRAGLOTTIS 1612 MALIG NEO SUBGLOTTIS 1613 MAL NEO CARTILAGE LARYNX 1618 MALIGNANT NEO LARYNX NEC 1619 MALIGNANT NEO LARYNX NOS 1620 MALIGNANT NEO TRACHEA 1622 MALIG NEO MAIN BRONCHUS 1623 MAL NEO UPPER LOBE LUNG 1624 MAL NEO MIDDLE LOBE LUNG 1625 MAL NEO LOWER LOBE LUNG 1628 MAL NEO BRONCH/LUNG NEC 1629 MAL NEO BRONCH/LUNG NOS 1630 MAL NEO PARIETAL PLEURA 1631 MAL NEO VISCERAL PLEURA 1638 MALIG NEOPL PLEURA NEC 1639 MALIG NEOPL PLEURA NOS 1640 MALIGNANT NEOPL THYMUS 1641 MALIGNANT NEOPL HEART 1642 MAL NEO ANT MEDIASTINUM April 3, 2015 Copyright Health Information Designs, LLC 9

10 1643 MAL NEO POST MEDIASTINUM 1648 MAL NEO MEDIASTINUM NEC 1649 MAL NEO MEDIASTINUM NOS 1650 MAL NEO UPPER RESP NOS 1658 MAL NEO THORAX/RESP NEC 1659 MAL NEO RESP SYSTEM NOS 1700 MAL NEO SKULL/FACE BONE 1701 MALIGNANT NEO MANDIBLE 1702 MALIG NEO VERTEBRAE 1703 MAL NEO RIBS/STERN/CLAV 1704 MAL NEO LONG BONES ARM 1705 MAL NEO BONES WRIST/HAND 1706 MAL NEO PELVIC GIRDLE 1707 MAL NEO LONG BONES LEG 1708 MAL NEO BONES ANKLE/FOOT 1709 MALIG NEOPL BONE NOS 1710 MAL NEO SOFT TISSUE HEAD 1712 MAL NEO SOFT TISSUE ARM 1713 MAL NEO SOFT TISSUE LEG 1714 MAL NEO SOFT TIS THORAX 1715 MAL NEO SOFT TIS ABDOMEN 1716 MAL NEO SOFT TIS PELVIS 1717 MAL NEOPL TRUNK NOS 1718 MAL NEO SOFT TISSUE NEC 1719 MAL NEO SOFT TISSUE NOS 1720 MALIG MELANOMA LIP 1721 MALIG MELANOMA EYELID 1722 MALIG MELANOMA EAR 1723 MAL MELANOM FACE NEC/NOS 1724 MAL MELANOMA SCALP/NECK 1725 MALIG MELANOMA TRUNK 1726 MALIG MELANOMA ARM 1727 MALIG MELANOMA LEG 1728 MALIG MELANOMA SKIN NEC 1729 MALIG MELANOMA SKIN NOS 1730 MALIG NEO SKIN LIP 1731 MALIG NEO SKIN EYELID 1732 MALIG NEO SKIN EAR 1733 MAL NEO SKIN FACE NEC 1734 MAL NEO SCALP/SKIN NECK April 3, 2015 Copyright Health Information Designs, LLC 10

11 1735 MALIG NEO SKIN TRUNK 1736 MALIG NEO SKIN ARM 1737 MALIG NEO SKIN LEG 1738 MALIG NEO SKIN NEC 1739 MALIG NEO SKIN NOS 1740 MALIG NEO NIPPLE 1741 MAL NEO BREAST-CENTRAL 1742 MAL NEO BREAST UP-INNER 1743 MAL NEO BREAST LOW-INNER 1744 MAL NEO BREAST UP-OUTER 1745 MAL NEO BREAST LOW-OUTER 1746 MAL NEO BREAST-AXILLARY 1748 MALIGN NEOPL BREAST NEC 1749 MALIGN NEOPL BREAST NOS 1750 MAL NEO MALE NIPPLE 1759 MAL NEO MALE BREAST NEC 1760 SKIN - KAPOSI'S SARCOMA 1761 SFT TISUE - KPSI'S SRCMA 1762 PALATE - KPSI's SARCOMA 1763 GI SITES - KPSI'S SRCOMA 1764 LUNG - KAPOSI'S SARCOMA 1765 LYM NDS - KPSI'S SARCOMA 1768 SPF STS - KPSI'S SARCOMA 1769 KAPOSI'S SARCOMA NOS 179 MALIG NEOPL UTERUS NOS 1800 MALIG NEO ENDOCERVIX 1801 MALIG NEO EXOCERVIX 1808 MALIG NEO CERVIX NEC 1809 MAL NEO CERVIX UTERI NOS 181 MALIGNANT NEOPL PLACENTA 1820 MALIG NEO CORPUS UTERI 1821 MAL NEO UTERINE ISTHMUS 1828 MAL NEO BODY UTERUS NEC 1830 MALIGN NEOPL OVARY 1832 MAL NEO FALLOPIAN TUBE 1833 MAL NEO BROAD LIGAMENT 1834 MALIG NEO PARAMETRIUM 1835 MAL NEO ROUND LIGAMENT 1838 MAL NEO ADNEXA NEC 1839 MAL NEO ADNEXA NOS April 3, 2015 Copyright Health Information Designs, LLC 11

12 1840 MALIGN NEOPL VAGINA 1841 MAL NEO LABIA MAJORA 1842 MAL NEO LABIA MINORA 1843 MALIGN NEOPL CLITORIS 1844 MALIGN NEOPL VULVA NOS 1848 MAL NEO FEMALE GENIT NEC 1849 MAL NEO FEMALE GENIT NOS 185 MALIGN NEOPL PROSTATE 1860 MAL NEO UNDESCEND TESTIS 1869 MALIG NEO TESTIS NEC 1871 MALIGN NEOPL PREPUCE 1872 MALIG NEO GLANS PENIS 1873 MALIG NEO PENIS BODY 1874 MALIG NEO PENIS NOS 1875 MALIG NEO EPIDIDYMIS 1876 MAL NEO SPERMATIC CORD 1877 MALIGN NEOPL SCROTUM 1878 MAL NEO MALE GENITAL NEC 1879 MAL NEO MALE GENITAL NOS 1880 MAL NEO BLADDER-TRIGONE 1881 MAL NEO BLADDER-DOME 1882 MAL NEO BLADDER-LATERAL 1883 MAL NEO BLADDER-ANTERIOR 1884 MAL NEO BLADDER-POST 1885 MAL NEO BLADDER NECK 1886 MAL NEO URETERIC ORIFICE 1887 MALIG NEO URACHUS 1888 MALIG NEO BLADDER NEC 1889 MALIG NEO BLADDER NOS 1890 MALIG NEOPL KIDNEY 1891 MALIG NEO RENAL PELVIS 1892 MALIGN NEOPL URETER 1893 MALIGN NEOPL URETHRA 1894 MAL NEO PARAURETHRAL 1898 MAL NEO URINARY NEC 1899 MAL NEO URINARY NOS 1900 MALIGN NEOPL EYEBALL 1901 MALIGN NEOPL ORBIT 1902 MAL NEO LACRIMAL GLAND 1903 MAL NEO CONJUNCTIVA April 3, 2015 Copyright Health Information Designs, LLC 12

13 1904 MALIGN NEOPL CORNEA 1905 MALIGN NEOPL RETINA 1906 MALIGN NEOPL CHOROID 1907 MAL NEO LACRIMAL DUCT 1908 MALIGN NEOPL EYE NEC 1909 MALIGN NEOPL EYE NOS 1910 MALIGN NEOPL CEREBRUM 1911 MALIG NEO FRONTAL LOBE 1912 MAL NEO TEMPORAL LOBE 1913 MAL NEO PARIETAL LOBE 1914 MAL NEO OCCIPITAL LOBE 1915 MAL NEO CEREB VENTRICLE 1916 MAL NEO CEREBELLUM NOS 1917 MAL NEO BRAIN STEM 1918 MALIG NEO BRAIN NEC 1919 MALIG NEO BRAIN NOS 1920 MAL NEO CRANIAL NERVES 1921 MAL NEO CEREBRAL MENING 1922 MAL NEO SPINAL CORD 1923 MAL NEO SPINAL MENINGES 1928 MAL NEO NERVOUS SYST NEC 1929 MAL NEO NERVOUS SYST NOS 193 MALIGN NEOPL THYROID 1940 MALIGN NEOPL ADRENAL 1941 MALIG NEO PARATHYROID 1943 MALIG NEO PITUITARY 1944 MALIGN NEO PINEAL GLAND 1945 MAL NEO CAROTID BODY 1946 MAL NEO PARAGANGLIA NEC 1948 MAL NEO ENDOCRINE NEC 1949 MAL NEO ENDOCRINE NOS 1950 MAL NEO HEAD/FACE/NECK 1951 MALIGN NEOPL THORAX 1952 MALIG NEO ABDOMEN 1953 MALIGN NEOPL PELVIS 1954 MALIGN NEOPL ARM 1955 MALIGN NEOPL LEG 1958 MALIG NEO SITE NEC 1960 MAL NEO LYMPH-HEAD/NECK 1961 MAL NEO LYMPH-INTRATHOR April 3, 2015 Copyright Health Information Designs, LLC 13

14 1962 MAL NEO LYMPH INTRA-ABD 1963 MAL NEO LYMPH-AXILLA/ARM 1965 MAL NEO LYMPH-INGUIN/LEG 1966 MAL NEO LYMPH-INTRAPELV 1968 MAL NEO LYMPH NODE-MULT 1969 MAL NEO LYMPH NODE NOS 1970 SECONDARY MALIG NEO LUNG 1971 SEC MAL NEO MEDIASTINUM 1972 SECOND MALIG NEO PLEURA 1973 SEC MALIG NEO RESP NEC 1974 SEC MALIG NEO SM BOWEL 1975 SEC MALIG NEO LG BOWEL 1976 SEC MAL NEO PERITONEUM 1977 SECOND MALIG NEO LIVER 1978 SEC MAL NEO GI NEC 1980 SECOND MALIG NEO KIDNEY 1981 SEC MALIG NEO URIN NEC 1982 SECONDARY MALIG NEO SKIN 1983 SEC MAL NEO BRAIN/SPINE 1984 SEC MALIG NEO NERVE NEC 1985 SECONDARY MALIG NEO BONE 1986 SECOND MALIG NEO OVARY 1987 SECOND MALIG NEO ADRENAL SECOND MALIG NEO BREAST SECOND MALIG NEO GENITAL SECONDARY MALIG NEO NEC 1990 MALIG NEO DISSEMINATED 1991 MALIGNANT NEOPLASM NOS 1992 MALIGNANT NEOPLASM ASSOCIATED WITH TRANSPLANT ORGAN RETCLSRC UNSP XTRNDL ORG RETICULOSARCOMA HEAD RETICULOSARCOMA THORAX RETICULOSARCOMA ABDOM RETICULOSARCOMA AXILLA RETICULOSARCOMA INGUIN RETICULOSARCOMA PELVIC RETICULOSARCOMA SPLEEN RETICULOSARCOMA MULT LYMPHSRC UNSP XTRNDL ORG LYMPHOSARCOMA HEAD April 3, 2015 Copyright Health Information Designs, LLC 14

15 20012 LYMPHOSARCOMA THORAX LYMPHOSARCOMA ABDOM LYMPHOSARCOMA AXILLA LYMPHOSARCOMA INGUIN LYMPHOSARCOMA PELVIC LYMPHOSARCOMA SPLEEN LYMPHOSARCOMA MULT BRKT TMR UNSP XTRNDL ORG BURKITT'S TUMOR HEAD BURKITT'S TUMOR THORAX BURKITT'S TUMOR ABDOM BURKITT'S TUMOR AXILLA BURKITT'S TUMOR INGUIN BURKITT'S TUMOR PELVIC BURKITT'S TUMOR SPLEEN BURKITT'S TUMOR MULT MARGINAL ZONE LYMPHOMA, UNSPECIFIED SITE, EXTRANODAL AND SOLID ORGAN SITES MARGINAL ZONE LYMPHOMA, LYMPH NODES OF HEAD, FACE, AND NECK MARGINAL ZONE LYMPHOMA, INTRATHORACIC LYMPH NODES MARGINAL ZONE LYMPHOMA, INTRAABDOMINAL LYMPH NODES MARGINAL ZONE LYMPHOMA, LYMPH NODES OF AXILLA AND UPPER LIMB MARGINAL ZONE LYMPHOMA, LYMPH NODES OF INGUINAL REGION AND LOWER LIMB MARGINAL ZONE LYMPHOMA, INTRAPELVIC LYMPH NODES MARGINAL ZONE LYMPHOMA, SPLEEN MARGINAL ZONE LYMPHOMA, LYMPH NODES OF MULTIPLE SITES MANTLE CELL LYMPHOMA, UNSPECIFIED SITE, EXTRANODAL AND SOLID ORGAN SITES MANTLE CELL LYMPHOMA, LYMPH NODES OF HEAD, FACE, AND NECK MANTLE CELL LYMPHOMA, INTRATHORACIC LYMPH NODES MANTLE CELL LYMPHOMA, INTRA-ABDOMINAL LYMPH NODES MANTLE CELL LYMPHOMA, LYMPH NODES OF AXILLA AND UPPER LIMB MANTLE CELL LYMPHOMA, LYMPH NODES OF INGUINAL REGION AND LOWER LIMB MANTLE CELL LYMPHOMA, INTRAPELVIC LYMPH NODES MANTLE CELL LYMPHOMA, SPLEEN MANTLE CELL LYMPHOMA, LYMPH NODES OF MULTIPLE SITES April 3, 2015 Copyright Health Information Designs, LLC 15

16 20050 PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA, UNSPECIFIED SITE, EXTRANODAL AND SOLID ORGAN SITES PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA, LYMPH NODES OF HEAD, FACE, AND NECK PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA, INTRATHORACIC LYMPH NODES PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA, INTRA- ABDOMINAL LYMPH NODES PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA, LYMPH NODES OF AXILLA AND UPPER LIMB PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA, LYMPH NODES OF INGUINAL REGION AND LOWER LIMB PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA, INTRAPELVIC LYMPH NODES PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA, SPLEEN PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA, LYMPH NODES OF MULTIPLE SITES ANAPLASTIC LARGE CELL LYMPHOMA, UNSPECIFIED SITE, EXTRANODAL AND SOLID ORGAN SITES ANAPLASTIC LARGE CELL LYMPHOMA, LYMPH NODES OF HEAD, FACE, AND NECK ANAPLASTIC LARGE CELL LYMPHOMA, INTRATHORACIC LYMPH NODES ANAPLASTIC LARGE CELL LYMPHOMA, INTRA-ABDOMINAL LYMPH NODES ANAPLASTIC LARGE CELL LYMPHOMA, LYMPH NODES OF AXILLA AND UPPER LIMB ANAPLASTIC LARGE CELL LYMPHOMA, LYMPH NODES OF INGUINAL REGION AND LOWER LIMB ANAPLASTIC LARGE CELL LYMPHOMA, INTRAPELVIC LYMPH NODES ANAPLASTIC LARGE CELL LYMPHOMA, SPLEEN ANAPLASTIC LARGE CELL LYMPHOMA, LYMPH NODES OF MULTIPLE SITES LARGE CELL LYMPHOMA, UNSPECIFIED SITE, EXTRANODAL AND SOLID ORGAN SITES LARGE CELL LYMPHOMA, LYMPH NODES OF HEAD, FACE, AND NECK LARGE CELL LYMPHOMA, INTRATHORACIC LYMPH NODES LARGE CELL LYMPHOMA, INTRA-ABDOMINAL LYMPH NODES LARGE CELL LYMPHOMA, LYMPH NODES OF AXILLA AND UPPER LIMB LARGE CELL LYMPHOMA, LYMPH NODES OF INGUINAL REGION AND LOWER LIMB LARGE CELL LYMPHOMA, INTRAPELVIC LYMPH NODES LARGE CELL LYMPHOMA, SPLEEN April 3, 2015 Copyright Health Information Designs, LLC 16

17 20078 LARGE CELL LYMPHOMA, LYMPH NODES OF MULTIPLE SITES OTH VARN UNSP XTRNDL ORG MIXED LYMPHOSARC HEAD MIXED LYMPHOSARC THORAX MIXED LYMPHOSARC ABDOM MIXED LYMPHOSARC AXILLA MIXED LYMPHOSARC INGUIN MIXED LYMPHOSARC PELVIC MIXED LYMPHOSARC SPLEEN MIXED LYMPHOSARC MULT HDGK PRG UNSP XTRNDL ORG HODGKINS PARAGRAN HEAD HODGKINS PARAGRAN THORAX HODGKINS PARAGRAN ABDOM HODGKINS PARAGRAN AXILLA HODGKINS PARAGRAN INGUIN HODGKINS PARAGRAN PELVIC HODGKINS PARAGRAN SPLEEN HODGKINS PARAGRAN MULT HDGK GRN UNSP XTRNDL ORG HODGKINS GRANULOM HEAD HODGKINS GRANULOM THORAX HODGKINS GRANULOM ABDOM HODGKINS GRANULOM AXILLA HODGKINS GRANULOM INGUIN HODGKINS GRANULOM PELVIC HODGKINS GRANULOM SPLEEN HODGKINS GRANULOM MULT HDGK SRC UNSP XTRNDL ORG HODGKINS SARCOMA HEAD HODGKINS SARCOMA THORAX HODGKINS SARCOMA ABDOM HODGKINS SARCOMA AXILLA HODGKINS SARCOMA INGUIN HODGKINS SARCOMA PELVIC HODGKINS SARCOMA SPLEEN HODGKINS SARCOMA MULT LYM-HST UNSP XTRNDL ORGN HODG LYMPH-HISTIO HEAD HODG LYMPH-HISTIO THORAX April 3, 2015 Copyright Health Information Designs, LLC 17

18 20143 HODG LYMPH-HISTIO ABDOM HODG LYMPH-HISTIO AXILLA HODG LYMPH-HISTIO INGUIN HODG LYMPH-HISTIO PELVIC HODG LYMPH-HISTIO SPLEEN HODG LYMPH-HISTIO MULT NDR SCLR UNSP XTRNDL ORG HODG NODUL SCLERO HEAD HODG NODUL SCLERO THORAX HODG NODUL SCLERO ABDOM HODG NODUL SCLERO AXILLA HODG NODUL SCLERO INGUIN HODG NODUL SCLERO PELVIC HODG NODUL SCLERO SPLEEN HODG NODUL SCLERO MULT MXD CELR UNSP XTRNDL ORG HODGKINS MIX CELL HEAD HODGKINS MIX CELL THORAX HODGKINS MIX CELL ABDOM HODGKINS MIX CELL AXILLA HODGKINS MIX CELL INGUIN HODGKINS MIX CELL PELVIC HODGKINS MIX CELL SPLEEN HODGKINS MIX CELL MULT LYM DPLT UNSP XTRNDL ORG HODG LYMPH DEPLET HEAD HODG LYMPH DEPLET THORAX HODG LYMPH DEPLET ABDOM HODG LYMPH DEPLET AXILLA HODG LYMPH DEPLET INGUIN HODG LYMPH DEPLET PELVIC HODG LYMPH DEPLET SPLEEN HODG LYMPH DEPLET MULT HDGK DIS UNSP XTRNDL ORG HODGKINS DIS NOS HEAD HODGKINS DIS NOS THORAX HODGKINS DIS NOS ABDOM HODGKINS DIS NOS AXILLA HODGKINS DIS NOS INGUIN HODGKINS DIS NOS PELVIC April 3, 2015 Copyright Health Information Designs, LLC 18

19 20197 HODGKINS DIS NOS SPLEEN HODGKINS DIS NOS MULT NDLR LYM UNSP XTRNDL ORG NODULAR LYMPHOMA HEAD NODULAR LYMPHOMA THORAX NODULAR LYMPHOMA ABDOM NODULAR LYMPHOMA AXILLA NODULAR LYMPHOMA INGUIN NODULAR LYMPHOMA PELVIC NODULAR LYMPHOMA SPLEEN NODULAR LYMPHOMA MULT MYCS FNG UNSP XTRNDL ORG MYCOSIS FUNGOIDES HEAD MYCOSIS FUNGOIDES THORAX MYCOSIS FUNGOIDES ABDOM MYCOSIS FUNGOIDES AXILLA MYCOSIS FUNGOIDES INGUIN MYCOSIS FUNGOIDES PELVIC MYCOSIS FUNGOIDES SPLEEN MYCOSIS FUNGOIDES MULT SZRY DIS UNSP XTRNDL ORG SEZARY'S DISEASE HEAD SEZARY'S DISEASE THORAX SEZARY'S DISEASE ABDOM SEZARY'S DISEASE AXILLA SEZARY'S DISEASE INGUIN SEZARY'S DISEASE PELVIC SEZARY'S DISEASE SPLEEN SEZARY'S DISEASE MULT MLG HIST UNSP XTRNDL ORG MAL HISTIOCYTOSIS HEAD MAL HISTIOCYTOSIS THORAX MAL HISTIOCYTOSIS ABDOM MAL HISTIOCYTOSIS AXILLA MAL HISTIOCYTOSIS INGUIN MAL HISTIOCYTOSIS PELVIC MAL HISTIOCYTOSIS SPLEEN MAL HISTIOCYTOSIS MULT LK RTCTL UNSP XTRNDL ORG HAIRY-CELL LEUKEM HEAD April 3, 2015 Copyright Health Information Designs, LLC 19

20 20242 HAIRY-CELL LEUKEM THORAX HAIRY-CELL LEUKEM ABDOM HAIRY-CELL LEUKEM AXILLA HAIRY-CELL LEUKEM INGUIN HAIRY-CELL LEUKEM PELVIC HAIRY-CELL LEUKEM SPLEEN HAIRY-CELL LEUKEM MULT LTR-SIWE UNSP XTRNDL ORG LETTERER-SIWE DIS HEAD LETTERER-SIWE DIS THORAX LETTERER-SIWE DIS ABDOM LETTERER-SIWE DIS AXILLA LETTERER-SIWE DIS INGUIN LETTERER-SIWE DIS PELVIC LETTERER-SIWE DIS SPLEEN LETTERER-SIWE DIS MULT MLG MAST UNSP XTRNDL ORG MAL MASTOCYTOSIS HEAD MAL MASTOCYTOSIS THORAX MAL MASTOCYTOSIS ABDOM MAL MASTOCYTOSIS AXILLA MAL MASTOCYTOSIS INGUIN MAL MASTOCYTOSIS PELVIC MAL MASTOCYTOSIS SPLEEN MAL MASTOCYTOSIS MULT PERIPHERAL T CELL LYMPHOMA, UNSPECIFIED SITE, EXTRANODAL AND SOLID ORGAN SITES PERIPHERAL T CELL LYMPHOMA, LYMPH NODES OF HEAD, FACE, AND NECK PERIPHERAL T CELL LYMPHOMA, INTRATHORACIC LYMPH NODES PERIPHERAL T CELL LYMPHOMA, INTRA-ABDOMINAL LYMPH NODES PERIPHERAL T CELL LYMPHOMA, LYMPH NODES OF AXILLA AND UPPER LIMB PERIPHERAL T CELL LYMPHOMA, LYMPH NODES OF INGUINAL REGION AND LOWER LIMB PERIPHERAL T CELL LYMPHOMA, INTRAPELVIC LYMPH NODES PERIPHERAL T CELL LYMPHOMA, SPLEEN PERIPHERAL T CELL LYMPHOMA, LYMPH NODES OF MULTIPLE SITES OTH LYMP UNSP XTRNDL ORG LYMPHOMAS NEC HEAD LYMPHOMAS NEC THORAX April 3, 2015 Copyright Health Information Designs, LLC 20

21 20283 LYMPHOMAS NEC ABDOM LYMPHOMAS NEC AXILLA LYMPHOMAS NEC INGUIN LYMPHOMAS NEC PELVIC LYMPHOMAS NEC SPLEEN LYMPHOMAS NEC MULT UNSP LYM UNSP XTRNDL ORG LYMPHOID MAL NEC HEAD LYMPHOID MAL NEC THORAX LYMPHOID MAL NEC ABDOM LYMPHOID MAL NEC AXILLA LYMPHOID MAL NEC INGUIN LYMPHOID MAL NEC PELVIC LYMPHOID MAL NEC SPLEEN LYMPHOID MAL NEC MULT MULTIPLE MYELOMA, WITHOUT MENTION OF HAVING ACHIEVED REMISSION MULT MYELM W REMISSION MULTIPLE MYELOMA, IN RELAPSE PLASMA CELL LEUKEMIA, WITHOUT MENTION OF HAVING ACHIEVED REMISSION PLSM CELL LEUK W RMSON PLASMA CELL LEUKEMIA, IN RELAPSE OTHER IMMUNOPROLIFERATIVE NEOPLASMS, WITHOUT MENTION OF HAVING ACHIEVED REMISSION OTH IMNPRFL NPL W RMSN OTHER IMMUNOPROLIFERATIVE NEOPLASMS, IN RELAPSE ACUTE LYMPHOID LEUKEMIA, WITHOUT MENTION OF HAVING ACHIEVED REMISSION ACT LYM LEUK W RMSION ACUTE LYMPHOID LEUKEMIA, IN RELAPSE CHRONIC LYMPHOID LEUKEMIA, WITHOUT MENTION OF HAVING ACHIEVED REMISSION CHR LYM LEUK W RMSION CHRONIC LYMPHOID LEUKEMIA, IN RELAPSE SUBACUTE LYMPHOID LEUKEMIA, WITHOUT MENTION OF HAVING ACHIEVED REMISSION SBAC LYM LEUK W RMSION SUBACUTE LYMPHOID LEUKEMIA, IN RELAPSE OTHER LYMPHOID LEUKEMIA, WITHOUT MENTION OF HAVING ACHIEVED REMISSION April 3, 2015 Copyright Health Information Designs, LLC 21

22 20481 OTH LYM LEUK W RMSION OTHER LYMPHOID LEUKEMIA, IN RELAPSE UNSPECIFIED LYMPHOID LEUKEMIA, WITHOUT MENTION OF HAVING ACHIEVED REMISSION UNS LYM LEUK W RMSION UNSPECIFIED LYMPHOID LEUKEMIA, IN RELAPSE ACUTE MYELOID LEUKEMIA, WITHOUT MENTION OF HAVING ACHIEVED REMISSION ACT MYL LEUK W RMSION ACUTE MYELOID LEUKEMIA, IN RELAPSE CHRONIC MYELOID LEUKEMIA, WITHOUT MENTION OF HAVING ACHIEVED REMISSION CHR MYL LEUK W RMSION CHRONIC MYELOID LEUKEMIA, IN RELAPSE SUBACUTE MYELOID LEUKEMIA, WITHOUT MENTION OF HAVING ACHIEVED REMISSION SBAC MYL LEUK W RMSION SUBACUTE MYELOID LEUKEMIA, IN RELAPSE MYELOID SARCOMA, WITHOUT MENTION OF HAVING ACHIEVED REMISSION MYL SRCOMA W RMSION MYELOID SARCOMA, IN RELAPSE OTHER MYELOID LEUKEMIA, WITHOUT MENTION OF HAVING ACHIEVED REMISSION OTH MYL LEUK W RMSION OTHER MYELOID LEUKEMIA, IN RELAPSE UNSPECIFIED MYELOID LEUKEMIA, WITHOUT MENTION OF HAVING ACHIEVED REMISSION UNS MYL LEUK W RMSION UNSPECIFIED MYELOID LEUKEMIA, IN RELAPSE ACUTE MONOCYTIC LEUKEMIA, WITHOUT MENTION OF HAVING ACHIEVED REMISSION ACT MONO LEUK W RMSION ACUTE MONOCYTIC LEUKEMIA, IN RELAPSE CHRONIC MONOCYTIC LEUKEMIA, WITHOUT MENTION OF HAVING ACHIEVED REMISSION CHR MONO LEUK W RMSION CHRONIC MONOCYTIC LEUKEMIA, IN RELAPSE SUBACUTE MONOCYTIC LEUKEMIA, WITHOUT MENTION OF HAVING ACHIEVED REMISSION SBAC MONO LEUK W RMSION SUBACUTE MONOCYTIC LEUKEMIA, IN RELAPSE April 3, 2015 Copyright Health Information Designs, LLC 22

23 20680 OTHER MONOCYTIC LEUKEMIA, WITHOUT MENTION OF HAVING ACHIEVED REMISSION OTH MONO LEUK W RMSION OTHER MONOCYTIC LEUKEMIA, IN RELAPSE UNSPECIFIED MONOCYTIC LEUKEMIA, WITHOUT MENTION OF HAVING ACHIEVED REMISSION UNS MONO LEUK W RMSION UNSPECIFIED MONOCYTIC LEUKEMIA, IN RELAPSE ACUTE ERYTHREMIA AND ERYTHROLEUKEMIA, WITHOUT MENTION OF HAVING ACHIEVED REMISSION ACT ERTH/ERYLK W RMSON ACUTE ERYTHREMIA AND ERYTHROLEUKEMIA, IN RELAPSE CHRONIC ERYTHREMIA, WITHOUT MENTION OF HAVING ACHIEVED REMISSION CHR ERYTHRM W REMISION CHRONIC ERYTHREMIA, IN RELAPSE MEGAKARYOCYTIC LEUKEMIA, WITHOUT MENTION OF HAVING ACHIEVED REMISSION MGKRYCYT LEUK W RMSION MEGAKARYOCYTIC LEUKEMIA, IN RELAPSE OTHER SPECIFIED LEUKEMIA, WITHOUT MENTION OF HAVING ACHIEVED REMISSION OTH SPF LEUK W REMSION OTHER SPECIFIED LEUKEMIA, IN RELAPSE ACUTE LEUKEMIA OF UNSPECIFIED CELL TYPE, WITHOUT MENTION OF HAVING ACHIEVED REMISSION ACT LEUK UNS CL W RMSON ACUTE LEUKEMIA OF UNSPECIFIED CELL TYPE, IN RELAPSE CHRONIC LEUKEMIA OF UNSPECIFIED CELL TYPE, WITHOUT MENTION OF HAVING ACHIEVED REMISSION CHR LEUK UNS CL W RMSON CHRONIC LEUKEMIA OF UNSPECIFIED CELL TYPE, IN RELAPSE SUBACUTE LEUKEMIA OF UNSPECIFIED CELL TYPE, WITHOUT MENTION OF HAVING ACHIEVED REMISSION SBAC LEUK UNS CL W RMSON SUBACUTE LEUKEMIA OF UNSPECIFIED CELL TYPE, IN RELAPSE OTHER LEUKEMIA OF UNSPECIFIED CELL TYPE, WITHOUT MENTION OF HAVING ACHIEVED REMISSION OTH LEUK UNS CL W RMSON OTHER LEUKEMIA OF UNSPECIFIED CELL TYPE, IN RELAPSE UNSPECIFIED LEUKEMIA, WITHOUT MENTION OF HAVING ACHIEVED REMISSION April 3, 2015 Copyright Health Information Designs, LLC 23

24 20891 LEUKEMIA NOS W REMISSION ICD-10 Code C000 C001 C002 C003 C004 C005 C006 C008 C009 C01 C020 C021 C022 C023 C024 C028 C029 C030 C031 C039 C040 C041 C048 C049 C050 C051 C052 C058 C059 C060 C061 C062 C0680 C0689 C069 Description MALIGNANT NEOPLASM OF EXTERNAL UPPER LIP MALIGNANT NEOPLASM OF EXTERNAL LOWER LIP MALIGNANT NEOPLASM OF EXTERNAL LIP, UNSPECIFIED MALIGNANT NEOPLASM OF UPPER LIP, INNER ASPECT MALIGNANT NEOPLASM OF LOWER LIP, INNER ASPECT MALIGNANT NEOPLASM OF LIP, UNSPECIFIED, INNER ASPECT MALIGNANT NEOPLASM OF COMMISSURE OF LIP, UNSPECIFIED MALIGNANT NEOPLASM OF OVERLAPPING SITES OF LIP MALIGNANT NEOPLASM OF LIP, UNSPECIFIED MALIGNANT NEOPLASM OF BASE OF TONGUE MALIGNANT NEOPLASM OF DORSAL SURFACE OF TONGUE MALIGNANT NEOPLASM OF BORDER OF TONGUE MALIGNANT NEOPLASM OF VENTRAL SURFACE OF TONGUE MALIGNANT NEOPLASM OF ANTERIOR TWO-THIRDS OF TONGUE, PART UNSPECIFIED MALIGNANT NEOPLASM OF LINGUAL TONSIL MALIGNANT NEOPLASM OF OVERLAPPING SITES OF TONGUE MALIGNANT NEOPLASM OF TONGUE, UNSPECIFIED MALIGNANT NEOPLASM OF UPPER GUM MALIGNANT NEOPLASM OF LOWER GUM MALIGNANT NEOPLASM OF GUM, UNSPECIFIED MALIGNANT NEOPLASM OF ANTERIOR FLOOR OF MOUTH MALIGNANT NEOPLASM OF LATERAL FLOOR OF MOUTH MALIGNANT NEOPLASM OF OVERLAPPING SITES OF FLOOR OF MOUTH MALIGNANT NEOPLASM OF FLOOR OF MOUTH, UNSPECIFIED MALIGNANT NEOPLASM OF HARD PALATE MALIGNANT NEOPLASM OF SOFT PALATE MALIGNANT NEOPLASM OF UVULA MALIGNANT NEOPLASM OF OVERLAPPING SITES OF PALATE MALIGNANT NEOPLASM OF PALATE, UNSPECIFIED MALIGNANT NEOPLASM OF CHEEK MUCOSA MALIGNANT NEOPLASM OF VESTIBULE OF MOUTH MALIGNANT NEOPLASM OF RETROMOLAR AREA MALIGNANT NEOPLASM OF OVERLAPPING SITES OF UNSPECIFIED PARTS OF MOUTH MALIGNANT NEOPLASM OF OVERLAPPING SITES OF OTHER PARTS OF MOUTH MALIGNANT NEOPLASM OF MOUTH, UNSPECIFIED April 3, 2015 Copyright Health Information Designs, LLC 24

25 C07 C080 C081 C089 C090 C091 C098 C099 C100 C101 C102 C103 C104 C108 C109 C110 C111 C112 C113 C118 C119 C12 C130 C131 C132 C138 C139 C140 C142 C148 C153 C154 C155 C158 C159 C160 C161 MALIGNANT NEOPLASM OF PAROTID GLAND MALIGNANT NEOPLASM OF SUBMANDIBULAR GLAND MALIGNANT NEOPLASM OF SUBLINGUAL GLAND MALIGNANT NEOPLASM OF MAJOR SALIVARY GLAND, UNSPECIFIED MALIGNANT NEOPLASM OF TONSILLAR FOSSA MALIGNANT NEOPLASM OF TONSILLAR PILLAR (ANTERIOR) (POSTERIOR) MALIGNANT NEOPLASM OF OVERLAPPING SITES OF TONSIL MALIGNANT NEOPLASM OF TONSIL, UNSPECIFIED MALIGNANT NEOPLASM OF VALLECULA MALIGNANT NEOPLASM OF ANTERIOR SURFACE OF EPIGLOTTIS MALIGNANT NEOPLASM OF LATERAL WALL OF OROPHARYNX MALIGNANT NEOPLASM OF POSTERIOR WALL OF OROPHARYNX MALIGNANT NEOPLASM OF BRANCHIAL CLEFT MALIGNANT NEOPLASM OF OVERLAPPING SITES OF OROPHARYNX MALIGNANT NEOPLASM OF OROPHARYNX, UNSPECIFIED MALIGNANT NEOPLASM OF SUPERIOR WALL OF NASOPHARYNX MALIGNANT NEOPLASM OF POSTERIOR WALL OF NASOPHARYNX MALIGNANT NEOPLASM OF LATERAL WALL OF NASOPHARYNX MALIGNANT NEOPLASM OF ANTERIOR WALL OF NASOPHARYNX MALIGNANT NEOPLASM OF OVERLAPPING SITES OF NASOPHARYNX MALIGNANT NEOPLASM OF NASOPHARYNX, UNSPECIFIED MALIGNANT NEOPLASM OF PYRIFORM SINUS MALIGNANT NEOPLASM OF POSTCRICOID REGION MALIGNANT NEOPLASM OF ARYEPIGLOTTIC FOLD, HYPOPHARYNGEAL ASPECT MALIGNANT NEOPLASM OF POSTERIOR WALL OF HYPOPHARYNX MALIGNANT NEOPLASM OF OVERLAPPING SITES OF HYPOPHARYNX MALIGNANT NEOPLASM OF HYPOPHARYNX, UNSPECIFIED MALIGNANT NEOPLASM OF PHARYNX, UNSPECIFIED MALIGNANT NEOPLASM OF WALDEYER'S RING MALIGNANT NEOPLASM OF OVERLAPPING SITES OF LIP, ORAL CAVITY AND PHARYNX MALIGNANT NEOPLASM OF UPPER THIRD OF ESOPHAGUS MALIGNANT NEOPLASM OF MIDDLE THIRD OF ESOPHAGUS MALIGNANT NEOPLASM OF LOWER THIRD OF ESOPHAGUS MALIGNANT NEOPLASM OF OVERLAPPING SITES OF ESOPHAGUS MALIGNANT NEOPLASM OF ESOPHAGUS, UNSPECIFIED MALIGNANT NEOPLASM OF CARDIA MALIGNANT NEOPLASM OF FUNDUS OF STOMACH April 3, 2015 Copyright Health Information Designs, LLC 25

26 C162 C163 C164 C165 C166 C168 C169 C170 C171 C172 C173 C178 C179 C180 C181 C182 C183 C184 C185 C186 C187 C188 C189 C19 C20 C210 C211 C212 C218 C220 C221 C222 C223 C224 C227 C228 MALIGNANT NEOPLASM OF BODY OF STOMACH MALIGNANT NEOPLASM OF PYLORIC ANTRUM MALIGNANT NEOPLASM OF PYLORUS MALIGNANT NEOPLASM OF LESSER CURVATURE OF STOMACH, UNSPECIFIED MALIGNANT NEOPLASM OF GREATER CURVATURE OF STOMACH, UNSPECIFIED MALIGNANT NEOPLASM OF OVERLAPPING SITES OF STOMACH MALIGNANT NEOPLASM OF STOMACH, UNSPECIFIED MALIGNANT NEOPLASM OF DUODENUM MALIGNANT NEOPLASM OF JEJUNUM MALIGNANT NEOPLASM OF ILEUM MECKEL'S DIVERTICULUM, MALIGNANT MALIGNANT NEOPLASM OF OVERLAPPING SITES OF SMALL INTESTINE MALIGNANT NEOPLASM OF SMALL INTESTINE, UNSPECIFIED MALIGNANT NEOPLASM OF CECUM MALIGNANT NEOPLASM OF APPENDIX MALIGNANT NEOPLASM OF ASCENDING COLON MALIGNANT NEOPLASM OF HEPATIC FLEXURE MALIGNANT NEOPLASM OF TRANSVERSE COLON MALIGNANT NEOPLASM OF SPLENIC FLEXURE MALIGNANT NEOPLASM OF DESCENDING COLON MALIGNANT NEOPLASM OF SIGMOID COLON MALIGNANT NEOPLASM OF OVERLAPPING SITES OF COLON MALIGNANT NEOPLASM OF COLON, UNSPECIFIED MALIGNANT NEOPLASM OF RECTOSIGMOID JUNCTION MALIGNANT NEOPLASM OF RECTUM MALIGNANT NEOPLASM OF ANUS, UNSPECIFIED MALIGNANT NEOPLASM OF ANAL CANAL MALIGNANT NEOPLASM OF CLOACOGENIC ZONE MALIGNANT NEOPLASM OF OVERLAPPING SITES OF RECTUM, ANUS AND ANAL CANAL LIVER CELL CARCINOMA INTRAHEPATIC BILE DUCT CARCINOMA HEPATOBLASTOMA ANGIOSARCOMA OF LIVER OTHER SARCOMAS OF LIVER OTHER SPECIFIED CARCINOMAS OF LIVER MALIGNANT NEOPLASM OF LIVER, PRIMARY, UNSPECIFIED AS TO TYPE April 3, 2015 Copyright Health Information Designs, LLC 26

27 C229 C23 C240 C241 C248 C249 C250 C251 C252 C253 C254 C257 C258 C259 C260 C261 C269 C300 C301 C310 C311 C312 C313 C318 C319 C320 C321 C322 C323 C328 C329 C33 C3400 C3401 C3402 C3410 C3411 MALIGNANT NEOPLASM OF LIVER, NOT SPECIFIED AS PRIMARY OR SECONDARY MALIGNANT NEOPLASM OF GALLBLADDER MALIGNANT NEOPLASM OF EXTRAHEPATIC BILE DUCT MALIGNANT NEOPLASM OF AMPULLA OF VATER MALIGNANT NEOPLASM OF OVERLAPPING SITES OF BILIARY TRACT MALIGNANT NEOPLASM OF BILIARY TRACT, UNSPECIFIED MALIGNANT NEOPLASM OF HEAD OF PANCREAS MALIGNANT NEOPLASM OF BODY OF PANCREAS MALIGNANT NEOPLASM OF TAIL OF PANCREAS MALIGNANT NEOPLASM OF PANCREATIC DUCT MALIGNANT NEOPLASM OF ENDOCRINE PANCREAS MALIGNANT NEOPLASM OF OTHER PARTS OF PANCREAS MALIGNANT NEOPLASM OF OVERLAPPING SITES OF PANCREAS MALIGNANT NEOPLASM OF PANCREAS, UNSPECIFIED MALIGNANT NEOPLASM OF INTESTINAL TRACT, PART UNSPECIFIED MALIGNANT NEOPLASM OF SPLEEN MALIGNANT NEOPLASM OF ILL-DEFINED SITES WITHIN THE DIGESTIVE SYSTEM MALIGNANT NEOPLASM OF NASAL CAVITY MALIGNANT NEOPLASM OF MIDDLE EAR MALIGNANT NEOPLASM OF MAXILLARY SINUS MALIGNANT NEOPLASM OF ETHMOIDAL SINUS MALIGNANT NEOPLASM OF FRONTAL SINUS MALIGNANT NEOPLASM OF SPHENOID SINUS MALIGNANT NEOPLASM OF OVERLAPPING SITES OF ACCESSORY SINUSES MALIGNANT NEOPLASM OF ACCESSORY SINUS, UNSPECIFIED MALIGNANT NEOPLASM OF GLOTTIS MALIGNANT NEOPLASM OF SUPRAGLOTTIS MALIGNANT NEOPLASM OF SUBGLOTTIS MALIGNANT NEOPLASM OF LARYNGEAL CARTILAGE MALIGNANT NEOPLASM OF OVERLAPPING SITES OF LARYNX MALIGNANT NEOPLASM OF LARYNX, UNSPECIFIED MALIGNANT NEOPLASM OF TRACHEA MALIGNANT NEOPLASM OF UNSPECIFIED MAIN BRONCHUS MALIGNANT NEOPLASM OF RIGHT MAIN BRONCHUS MALIGNANT NEOPLASM OF LEFT MAIN BRONCHUS MALIGNANT NEOPLASM OF UPPER LOBE, UNSPECIFIED BRONCHUS OR LUNG MALIGNANT NEOPLASM OF UPPER LOBE, RIGHT BRONCHUS OR LUNG April 3, 2015 Copyright Health Information Designs, LLC 27

28 C3412 C342 C3430 C3431 C3432 C3480 C3481 C3482 C3490 C3491 C3492 C37 C380 C381 C382 C383 C384 C388 C390 C399 C4000 C4001 C4002 C4010 C4011 C4012 C4020 MALIGNANT NEOPLASM OF UPPER LOBE, LEFT BRONCHUS OR LUNG MALIGNANT NEOPLASM OF MIDDLE LOBE, BRONCHUS OR LUNG MALIGNANT NEOPLASM OF LOWER LOBE, UNSPECIFIED BRONCHUS OR LUNG MALIGNANT NEOPLASM OF LOWER LOBE, RIGHT BRONCHUS OR LUNG MALIGNANT NEOPLASM OF LOWER LOBE, LEFT BRONCHUS OR LUNG MALIGNANT NEOPLASM OF OVERLAPPING SITES OF UNSPECIFIED BRONCHUS AND LUNG MALIGNANT NEOPLASM OF OVERLAPPING SITES OF RIGHT BRONCHUS AND LUNG MALIGNANT NEOPLASM OF OVERLAPPING SITES OF LEFT BRONCHUS AND LUNG MALIGNANT NEOPLASM OF UNSPECIFIED PART OF UNSPECIFIED BRONCHUS OR LUNG MALIGNANT NEOPLASM OF UNSPECIFIED PART OF RIGHT BRONCHUS OR LUNG MALIGNANT NEOPLASM OF UNSPECIFIED PART OF LEFT BRONCHUS OR LUNG MALIGNANT NEOPLASM OF THYMUS MALIGNANT NEOPLASM OF HEART MALIGNANT NEOPLASM OF ANTERIOR MEDIASTINUM MALIGNANT NEOPLASM OF POSTERIOR MEDIASTINUM MALIGNANT NEOPLASM OF MEDIASTINUM, PART UNSPECIFIED MALIGNANT NEOPLASM OF PLEURA MALIGNANT NEOPLASM OF OVERLAPPING SITES OF HEART, MEDIASTINUM AND PLEURA MALIGNANT NEOPLASM OF UPPER RESPIRATORY TRACT, PART UNSPECIFIED MALIGNANT NEOPLASM OF LOWER RESPIRATORY TRACT, PART UNSPECIFIED MALIGNANT NEOPLASM OF SCAPULA AND LONG BONES OF UNSPECIFIED UPPER LIMB MALIGNANT NEOPLASM OF SCAPULA AND LONG BONES OF RIGHT UPPER LIMB MALIGNANT NEOPLASM OF SCAPULA AND LONG BONES OF LEFT UPPER LIMB MALIGNANT NEOPLASM OF SHORT BONES OF UNSPECIFIED UPPER LIMB MALIGNANT NEOPLASM OF SHORT BONES OF RIGHT UPPER LIMB MALIGNANT NEOPLASM OF SHORT BONES OF LEFT UPPER LIMB MALIGNANT NEOPLASM OF LONG BONES OF UNSPECIFIED LOWER LIMB April 3, 2015 Copyright Health Information Designs, LLC 28

29 C4021 C4022 C4030 C4031 C4032 C4080 C4081 C4082 C4090 C4091 C4092 C410 C411 C412 C413 C414 C419 C430 C4310 C4311 C4312 C4320 C4321 C4322 C4330 C4331 C4339 C434 C4351 C4352 MALIGNANT NEOPLASM OF LONG BONES OF RIGHT LOWER LIMB MALIGNANT NEOPLASM OF LONG BONES OF LEFT LOWER LIMB MALIGNANT NEOPLASM OF SHORT BONES OF UNSPECIFIED LOWER LIMB MALIGNANT NEOPLASM OF SHORT BONES OF RIGHT LOWER LIMB MALIGNANT NEOPLASM OF SHORT BONES OF LEFT LOWER LIMB MALIGNANT NEOPLASM OF OVERLAPPING SITES OF BONE AND ARTICULAR CARTILAGE OF UNSPECIFIED LIMB MALIGNANT NEOPLASM OF OVERLAPPING SITES OF BONE AND ARTICULAR CARTILAGE OF RIGHT LIMB MALIGNANT NEOPLASM OF OVERLAPPING SITES OF BONE AND ARTICULAR CARTILAGE OF LEFT LIMB MALIGNANT NEOPLASM OF UNSPECIFIED BONES AND ARTICULAR CARTILAGE OF UNSPECIFIED LIMB MALIGNANT NEOPLASM OF UNSPECIFIED BONES AND ARTICULAR CARTILAGE OF RIGHT LIMB MALIGNANT NEOPLASM OF UNSPECIFIED BONES AND ARTICULAR CARTILAGE OF LEFT LIMB MALIGNANT NEOPLASM OF BONES OF SKULL AND FACE MALIGNANT NEOPLASM OF MANDIBLE MALIGNANT NEOPLASM OF VERTEBRAL COLUMN MALIGNANT NEOPLASM OF RIBS, STERNUM AND CLAVICLE MALIGNANT NEOPLASM OF PELVIC BONES, SACRUM AND COCCYX MALIGNANT NEOPLASM OF BONE AND ARTICULAR CARTILAGE, UNSPECIFIED MALIGNANT MELANOMA OF LIP MALIGNANT MELANOMA OF UNSPECIFIED EYELID, INCLUDING CANTHUS MALIGNANT MELANOMA OF RIGHT EYELID, INCLUDING CANTHUS MALIGNANT MELANOMA OF LEFT EYELID, INCLUDING CANTHUS MALIGNANT MELANOMA OF UNSPECIFIED EAR AND EXTERNAL AURICULAR CANAL MALIGNANT MELANOMA OF RIGHT EAR AND EXTERNAL AURICULAR CANAL MALIGNANT MELANOMA OF LEFT EAR AND EXTERNAL AURICULAR CANAL MALIGNANT MELANOMA OF UNSPECIFIED PART OF FACE MALIGNANT MELANOMA OF NOSE MALIGNANT MELANOMA OF OTHER PARTS OF FACE MALIGNANT MELANOMA OF SCALP AND NECK MALIGNANT MELANOMA OF ANAL SKIN MALIGNANT MELANOMA OF SKIN OF BREAST April 3, 2015 Copyright Health Information Designs, LLC 29

30 C4359 C4360 C4361 C4362 C4370 C4371 C4372 C438 C439 C450 C451 C452 C457 C459 C460 C461 C462 C463 C464 C4650 C4651 C4652 C467 C469 C470 C4710 C4711 C4712 C4720 C4721 C4722 MALIGNANT MELANOMA OF OTHER PART OF TRUNK MALIGNANT MELANOMA OF UNSPECIFIED UPPER LIMB, INCLUDING SHOULDER MALIGNANT MELANOMA OF RIGHT UPPER LIMB, INCLUDING SHOULDER MALIGNANT MELANOMA OF LEFT UPPER LIMB, INCLUDING SHOULDER MALIGNANT MELANOMA OF UNSPECIFIED LOWER LIMB, INCLUDING HIP MALIGNANT MELANOMA OF RIGHT LOWER LIMB, INCLUDING HIP MALIGNANT MELANOMA OF LEFT LOWER LIMB, INCLUDING HIP MALIGNANT MELANOMA OF OVERLAPPING SITES OF SKIN MALIGNANT MELANOMA OF SKIN, UNSPECIFIED MESOTHELIOMA OF PLEURA MESOTHELIOMA OF PERITONEUM MESOTHELIOMA OF PERICARDIUM MESOTHELIOMA OF OTHER SITES MESOTHELIOMA, UNSPECIFIED KAPOSI'S SARCOMA OF SKIN KAPOSI'S SARCOMA OF SOFT TISSUE KAPOSI'S SARCOMA OF PALATE KAPOSI'S SARCOMA OF LYMPH NODES KAPOSI'S SARCOMA OF GASTROINTESTINAL SITES KAPOSI'S SARCOMA OF UNSPECIFIED LUNG KAPOSI'S SARCOMA OF RIGHT LUNG KAPOSI'S SARCOMA OF LEFT LUNG KAPOSI'S SARCOMA OF OTHER SITES KAPOSI'S SARCOMA, UNSPECIFIED MALIGNANT NEOPLASM OF PERIPHERAL NERVES OF HEAD, FACE AND NECK MALIGNANT NEOPLASM OF PERIPHERAL NERVES OF UNSPECIFIED UPPER LIMB, INCLUDING SHOULDER MALIGNANT NEOPLASM OF PERIPHERAL NERVES OF RIGHT UPPER LIMB, INCLUDING SHOULDER MALIGNANT NEOPLASM OF PERIPHERAL NERVES OF LEFT UPPER LIMB, INCLUDING SHOULDER MALIGNANT NEOPLASM OF PERIPHERAL NERVES OF UNSPECIFIED LOWER LIMB, INCLUDING HIP MALIGNANT NEOPLASM OF PERIPHERAL NERVES OF RIGHT LOWER LIMB, INCLUDING HIP MALIGNANT NEOPLASM OF PERIPHERAL NERVES OF LEFT LOWER LIMB, INCLUDING HIP April 3, 2015 Copyright Health Information Designs, LLC 30

31 C473 C474 C475 C476 C478 C479 C480 C481 C482 C488 C490 C4910 C4911 C4912 C4920 C4921 C4922 C493 C494 C495 C496 C498 C499 C50011 MALIGNANT NEOPLASM OF PERIPHERAL NERVES OF THORAX MALIGNANT NEOPLASM OF PERIPHERAL NERVES OF ABDOMEN MALIGNANT NEOPLASM OF PERIPHERAL NERVES OF PELVIS MALIGNANT NEOPLASM OF PERIPHERAL NERVES OF TRUNK, UNSPECIFIED MALIGNANT NEOPLASM OF OVERLAPPING SITES OF PERIPHERAL NERVES AND AUTONOMIC NERVOUS SYSTEM MALIGNANT NEOPLASM OF PERIPHERAL NERVES AND AUTONOMIC NERVOUS SYSTEM, UNSPECIFIED MALIGNANT NEOPLASM OF RETROPERITONEUM MALIGNANT NEOPLASM OF SPECIFIED PARTS OF PERITONEUM MALIGNANT NEOPLASM OF PERITONEUM, UNSPECIFIED MALIGNANT NEOPLASM OF OVERLAPPING SITES OF RETROPERITONEUM AND PERITONEUM MALIGNANT NEOPLASM OF CONNECTIVE AND SOFT TISSUE OF HEAD, FACE AND NECK MALIGNANT NEOPLASM OF CONNECTIVE AND SOFT TISSUE OF UNSPECIFIED UPPER LIMB, INCLUDING SHOULDER MALIGNANT NEOPLASM OF CONNECTIVE AND SOFT TISSUE OF RIGHT UPPER LIMB, INCLUDING SHOULDER MALIGNANT NEOPLASM OF CONNECTIVE AND SOFT TISSUE OF LEFT UPPER LIMB, INCLUDING SHOULDER MALIGNANT NEOPLASM OF CONNECTIVE AND SOFT TISSUE OF UNSPECIFIED LOWER LIMB, INCLUDING HIP MALIGNANT NEOPLASM OF CONNECTIVE AND SOFT TISSUE OF RIGHT LOWER LIMB, INCLUDING HIP MALIGNANT NEOPLASM OF CONNECTIVE AND SOFT TISSUE OF LEFT LOWER LIMB, INCLUDING HIP MALIGNANT NEOPLASM OF CONNECTIVE AND SOFT TISSUE OF THORAX MALIGNANT NEOPLASM OF CONNECTIVE AND SOFT TISSUE OF ABDOMEN MALIGNANT NEOPLASM OF CONNECTIVE AND SOFT TISSUE OF PELVIS MALIGNANT NEOPLASM OF CONNECTIVE AND SOFT TISSUE OF TRUNK, UNSPECIFIED MALIGNANT NEOPLASM OF OVERLAPPING SITES OF CONNECTIVE AND SOFT TISSUE MALIGNANT NEOPLASM OF CONNECTIVE AND SOFT TISSUE, UNSPECIFIED MALIGNANT NEOPLASM OF NIPPLE AND AREOLA, RIGHT FEMALE BREAST April 3, 2015 Copyright Health Information Designs, LLC 31

32 C50012 C50019 C50021 C50022 C50029 C50111 C50112 C50119 C50121 C50122 C50129 C50211 C50212 C50219 C50221 C50222 C50229 C50311 C50312 C50319 C50321 C50322 MALIGNANT NEOPLASM OF NIPPLE AND AREOLA, LEFT FEMALE BREAST MALIGNANT NEOPLASM OF NIPPLE AND AREOLA, UNSPECIFIED FEMALE BREAST MALIGNANT NEOPLASM OF NIPPLE AND AREOLA, RIGHT MALE BREAST MALIGNANT NEOPLASM OF NIPPLE AND AREOLA, LEFT MALE BREAST MALIGNANT NEOPLASM OF NIPPLE AND AREOLA, UNSPECIFIED MALE BREAST MALIGNANT NEOPLASM OF CENTRAL PORTION OF RIGHT FEMALE BREAST MALIGNANT NEOPLASM OF CENTRAL PORTION OF LEFT FEMALE BREAST MALIGNANT NEOPLASM OF CENTRAL PORTION OF UNSPECIFIED FEMALE BREAST MALIGNANT NEOPLASM OF CENTRAL PORTION OF RIGHT MALE BREAST MALIGNANT NEOPLASM OF CENTRAL PORTION OF LEFT MALE BREAST MALIGNANT NEOPLASM OF CENTRAL PORTION OF UNSPECIFIED MALE BREAST MALIGNANT NEOPLASM OF UPPER-INNER QUADRANT OF RIGHT FEMALE BREAST MALIGNANT NEOPLASM OF UPPER-INNER QUADRANT OF LEFT FEMALE BREAST MALIGNANT NEOPLASM OF UPPER-INNER QUADRANT OF UNSPECIFIED FEMALE BREAST MALIGNANT NEOPLASM OF UPPER-INNER QUADRANT OF RIGHT MALE BREAST MALIGNANT NEOPLASM OF UPPER-INNER QUADRANT OF LEFT MALE BREAST MALIGNANT NEOPLASM OF UPPER-INNER QUADRANT OF UNSPECIFIED MALE BREAST MALIGNANT NEOPLASM OF LOWER-INNER QUADRANT OF RIGHT FEMALE BREAST MALIGNANT NEOPLASM OF LOWER-INNER QUADRANT OF LEFT FEMALE BREAST MALIGNANT NEOPLASM OF LOWER-INNER QUADRANT OF UNSPECIFIED FEMALE BREAST MALIGNANT NEOPLASM OF LOWER-INNER QUADRANT OF RIGHT MALE BREAST MALIGNANT NEOPLASM OF LOWER-INNER QUADRANT OF LEFT MALE BREAST April 3, 2015 Copyright Health Information Designs, LLC 32

33 C50329 C50411 C50412 C50419 C50421 C50422 C50429 C50511 C50512 C50519 C50521 C50522 C50529 C50611 C50612 C50619 C50621 C50622 C50629 C50811 C50812 C50819 C50821 MALIGNANT NEOPLASM OF LOWER-INNER QUADRANT OF UNSPECIFIED MALE BREAST MALIGNANT NEOPLASM OF UPPER-OUTER QUADRANT OF RIGHT FEMALE BREAST MALIGNANT NEOPLASM OF UPPER-OUTER QUADRANT OF LEFT FEMALE BREAST MALIGNANT NEOPLASM OF UPPER-OUTER QUADRANT OF UNSPECIFIED FEMALE BREAST MALIGNANT NEOPLASM OF UPPER-OUTER QUADRANT OF RIGHT MALE BREAST MALIGNANT NEOPLASM OF UPPER-OUTER QUADRANT OF LEFT MALE BREAST MALIGNANT NEOPLASM OF UPPER-OUTER QUADRANT OF UNSPECIFIED MALE BREAST MALIGNANT NEOPLASM OF LOWER-OUTER QUADRANT OF RIGHT FEMALE BREAST MALIGNANT NEOPLASM OF LOWER-OUTER QUADRANT OF LEFT FEMALE BREAST MALIGNANT NEOPLASM OF LOWER-OUTER QUADRANT OF UNSPECIFIED FEMALE BREAST MALIGNANT NEOPLASM OF LOWER-OUTER QUADRANT OF RIGHT MALE BREAST MALIGNANT NEOPLASM OF LOWER-OUTER QUADRANT OF LEFT MALE BREAST MALIGNANT NEOPLASM OF LOWER-OUTER QUADRANT OF UNSPECIFIED MALE BREAST MALIGNANT NEOPLASM OF AXILLARY TAIL OF RIGHT FEMALE BREAST MALIGNANT NEOPLASM OF AXILLARY TAIL OF LEFT FEMALE BREAST MALIGNANT NEOPLASM OF AXILLARY TAIL OF UNSPECIFIED FEMALE BREAST MALIGNANT NEOPLASM OF AXILLARY TAIL OF RIGHT MALE BREAST MALIGNANT NEOPLASM OF AXILLARY TAIL OF LEFT MALE BREAST MALIGNANT NEOPLASM OF AXILLARY TAIL OF UNSPECIFIED MALE BREAST MALIGNANT NEOPLASM OF OVERLAPPING SITES OF RIGHT FEMALE BREAST MALIGNANT NEOPLASM OF OVERLAPPING SITES OF LEFT FEMALE BREAST MALIGNANT NEOPLASM OF OVERLAPPING SITES OF UNSPECIFIED FEMALE BREAST MALIGNANT NEOPLASM OF OVERLAPPING SITES OF RIGHT MALE BREAST April 3, 2015 Copyright Health Information Designs, LLC 33

34 C50822 C50829 C50911 C50912 C50919 C50921 C50922 C50929 C510 C511 C512 C518 C519 C52 C530 C531 C538 C539 C540 C541 C542 C543 C548 C549 C55 C561 C562 C569 C5700 C5701 C5702 C5710 C5711 MALIGNANT NEOPLASM OF OVERLAPPING SITES OF LEFT MALE BREAST MALIGNANT NEOPLASM OF OVERLAPPING SITES OF UNSPECIFIED MALE BREAST MALIGNANT NEOPLASM OF UNSPECIFIED SITE OF RIGHT FEMALE BREAST MALIGNANT NEOPLASM OF UNSPECIFIED SITE OF LEFT FEMALE BREAST MALIGNANT NEOPLASM OF UNSPECIFIED SITE OF UNSPECIFIED FEMALE BREAST MALIGNANT NEOPLASM OF UNSPECIFIED SITE OF RIGHT MALE BREAST MALIGNANT NEOPLASM OF UNSPECIFIED SITE OF LEFT MALE BREAST MALIGNANT NEOPLASM OF UNSPECIFIED SITE OF UNSPECIFIED MALE BREAST MALIGNANT NEOPLASM OF LABIUM MAJUS MALIGNANT NEOPLASM OF LABIUM MINUS MALIGNANT NEOPLASM OF CLITORIS MALIGNANT NEOPLASM OF OVERLAPPING SITES OF VULVA MALIGNANT NEOPLASM OF VULVA, UNSPECIFIED MALIGNANT NEOPLASM OF VAGINA MALIGNANT NEOPLASM OF ENDOCERVIX MALIGNANT NEOPLASM OF EXOCERVIX MALIGNANT NEOPLASM OF OVERLAPPING SITES OF CERVIX UTERI MALIGNANT NEOPLASM OF CERVIX UTERI, UNSPECIFIED MALIGNANT NEOPLASM OF ISTHMUS UTERI MALIGNANT NEOPLASM OF ENDOMETRIUM MALIGNANT NEOPLASM OF MYOMETRIUM MALIGNANT NEOPLASM OF FUNDUS UTERI MALIGNANT NEOPLASM OF OVERLAPPING SITES OF CORPUS UTERI MALIGNANT NEOPLASM OF CORPUS UTERI, UNSPECIFIED MALIGNANT NEOPLASM OF UTERUS, PART UNSPECIFIED MALIGNANT NEOPLASM OF RIGHT OVARY MALIGNANT NEOPLASM OF LEFT OVARY MALIGNANT NEOPLASM OF UNSPECIFIED OVARY MALIGNANT NEOPLASM OF UNSPECIFIED FALLOPIAN TUBE MALIGNANT NEOPLASM OF RIGHT FALLOPIAN TUBE MALIGNANT NEOPLASM OF LEFT FALLOPIAN TUBE MALIGNANT NEOPLASM OF UNSPECIFIED BROAD LIGAMENT MALIGNANT NEOPLASM OF RIGHT BROAD LIGAMENT April 3, 2015 Copyright Health Information Designs, LLC 34

35 C5712 C5720 C5721 C5722 C573 C574 C577 C578 C579 C58 C600 C601 C602 C608 C609 C61 C6200 C6201 C6202 C6210 C6211 C6212 C6290 C6291 C6292 C6300 C6301 C6302 C6310 C6311 C6312 C632 C637 C638 MALIGNANT NEOPLASM OF LEFT BROAD LIGAMENT MALIGNANT NEOPLASM OF UNSPECIFIED ROUND LIGAMENT MALIGNANT NEOPLASM OF RIGHT ROUND LIGAMENT MALIGNANT NEOPLASM OF LEFT ROUND LIGAMENT MALIGNANT NEOPLASM OF PARAMETRIUM MALIGNANT NEOPLASM OF UTERINE ADNEXA, UNSPECIFIED MALIGNANT NEOPLASM OF OTHER SPECIFIED FEMALE GENITAL ORGANS MALIGNANT NEOPLASM OF OVERLAPPING SITES OF FEMALE GENITAL ORGANS MALIGNANT NEOPLASM OF FEMALE GENITAL ORGAN, UNSPECIFIED MALIGNANT NEOPLASM OF PLACENTA MALIGNANT NEOPLASM OF PREPUCE MALIGNANT NEOPLASM OF GLANS PENIS MALIGNANT NEOPLASM OF BODY OF PENIS MALIGNANT NEOPLASM OF OVERLAPPING SITES OF PENIS MALIGNANT NEOPLASM OF PENIS, UNSPECIFIED MALIGNANT NEOPLASM OF PROSTATE MALIGNANT NEOPLASM OF UNSPECIFIED UNDESCENDED TESTIS MALIGNANT NEOPLASM OF UNDESCENDED RIGHT TESTIS MALIGNANT NEOPLASM OF UNDESCENDED LEFT TESTIS MALIGNANT NEOPLASM OF UNSPECIFIED DESCENDED TESTIS MALIGNANT NEOPLASM OF DESCENDED RIGHT TESTIS MALIGNANT NEOPLASM OF DESCENDED LEFT TESTIS MALIGNANT NEOPLASM OF UNSPECIFIED TESTIS, UNSPECIFIED WHETHER DESCENDED OR UNDESCENDED MALIGNANT NEOPLASM OF RIGHT TESTIS, UNSPECIFIED WHETHER DESCENDED OR UNDESCENDED MALIGNANT NEOPLASM OF LEFT TESTIS, UNSPECIFIED WHETHER DESCENDED OR UNDESCENDED MALIGNANT NEOPLASM OF UNSPECIFIED EPIDIDYMIS MALIGNANT NEOPLASM OF RIGHT EPIDIDYMIS MALIGNANT NEOPLASM OF LEFT EPIDIDYMIS MALIGNANT NEOPLASM OF UNSPECIFIED SPERMATIC CORD MALIGNANT NEOPLASM OF RIGHT SPERMATIC CORD MALIGNANT NEOPLASM OF LEFT SPERMATIC CORD MALIGNANT NEOPLASM OF SCROTUM MALIGNANT NEOPLASM OF OTHER SPECIFIED MALE GENITAL ORGANS MALIGNANT NEOPLASM OF OVERLAPPING SITES OF MALE GENITAL ORGANS April 3, 2015 Copyright Health Information Designs, LLC 35

82330 CALCIUM; IONIZED. ICD-10 Codes that Support Medical Necessity. ICD-10 Code. Description. A15.0 Tuberculosis of lung

82330 CALCIUM; IONIZED. ICD-10 Codes that Support Medical Necessity. ICD-10 Code. Description. A15.0 Tuberculosis of lung 82330 CALCIUM; IONIZED ICD-10 Codes that Support Medical Necessity ICD-10 Code Description A15.0 Tuberculosis of lung A15.4 Tuberculosis of intrathoracic lymph nodes A15.5 Tuberculosis of larynx, trachea

More information

Cancer Association of South Africa (CANSA)

Cancer Association of South Africa (CANSA) Cancer Association of South Africa (CANSA) Fact Sheet on ICD-10 Coding of Neoplasms Introduction The International Statistical Classification of Diseases and Related Health Problems, 10 th Revision (ICD-10)

More information

WLH Tumor Frequencies between cohort enrollment and 31-Dec Below the Women Lifestyle and Health tumor frequencies are tabulated according to:

WLH Tumor Frequencies between cohort enrollment and 31-Dec Below the Women Lifestyle and Health tumor frequencies are tabulated according to: DESCRIPTION Below the Women Lifestyle and Health tumor frequencies are tabulated according to: Benign =171 (Cervix uteri) treated as not recorded =191 (non-melanoma skin cancer) treated as not recorded

More information

WLH Tumor Frequencies between cohort enrollment and 31-Dec Below the Women Lifestyle and Health tumor frequencies are tabulated according to:

WLH Tumor Frequencies between cohort enrollment and 31-Dec Below the Women Lifestyle and Health tumor frequencies are tabulated according to: WLH Tumor Frequencies between cohort enrollment and 31-Dec 2012 DESCRIPTION Below the Women Lifestyle and Health tumor frequencies are tabulated according to: Benign =171 (Cervix uteri) treated as not

More information

SCCA REFERENCE MANUAL ICD-10

SCCA REFERENCE MANUAL ICD-10 SCCA REFERENCE MANUAL ICD-10 NORTHWEST HOSPITAL 1 BREAST CANCER BREAST (INC. PAGET S DISEASE) 0 - Nipple and areola 1 - Central portion 2 - Upper-inner quadrant 3 - Lower-inner quadrant 4 - Upper-outer

More information

Erythropoiesis-Stimulating Agents

Erythropoiesis-Stimulating Agents Texas Prior Authorization Program Clinical Edit Criteria Drug/Drug Class Erythropoiesis-Stimulating Agents Clinical Edit Information Included in this Document Drugs requiring prior authorization: the list

More information

Serum Iron Studies

Serum Iron Studies 190.18 - Serum Iron Studies Serum iron studies are useful in the evaluation of disorders of iron metabolism, particularly iron deficiency and iron excess. Iron studies are best performed when the patient

More information

ICD-10 and Radiation Oncology

ICD-10 and Radiation Oncology ICD-10 and Radiation Oncology Steven M. Verno, CEMCS ICD-10 and Radiation Oncology Steven M. Verno, CEMCS September 23, 2008 Note: ICD-9-CM and ICD-10 are owned and copyrighted by the World Health Organization.

More information

Clinical Coding for CRS Standards

Clinical Coding for CRS Standards Clinical Coding for CRS Standards The following appendices set out the amended PRIMARY DIAGNOSIS coding structure to be used for the monitoring of cancer waiting times following the implementation of 4th

More information

Texas Prior Authorization Program Clinical Edit Criteria

Texas Prior Authorization Program Clinical Edit Criteria Texas Prior Authorization Program Clinical Edit Criteria Drug/Drug Class Growth Hormone Clinical Edit Information Included in this Document Excluding Serostim / Zorbtive Serostim Drugs requiring prior

More information

Texas Prior Authorization Program Clinical Criteria. Revisions were recommended by MCOs and VDP to ensure appropriate utilization.

Texas Prior Authorization Program Clinical Criteria. Revisions were recommended by MCOs and VDP to ensure appropriate utilization. Texas Prior Authorization Program Clinical Criteria Drug/Drug Class Growth Hormone Revisions were recommended by MCOs and VDP to ensure appropriate utilization. Clinical PA Information Included in this

More information

CLINICAL MEDICATION POLICY

CLINICAL MEDICATION POLICY Policy Name: Policy Number: Approved By: CLINICAL MEDICATION POLICY Keytruda (pembrolizumab) MP-014-MD-DE Medical Management; Clinical Pharmacy Provider Notice Date: 01/15/2018; 08/01/2017; 06/01/2016

More information

Model Policy. Coverage of Proton Therapy

Model Policy. Coverage of Proton Therapy Model Policy Coverage of Proton Therapy Last Revised - February 2019 INTRODUCTION Proton therapy is a technologically advanced method to deliver curative radiation doses to cancerous tumors. The unique

More information

Contractor Information. LCD Information. Local Coverage Determination (LCD): Computerized Axial Tomography of the Chest/Thorax (L34416)

Contractor Information. LCD Information. Local Coverage Determination (LCD): Computerized Axial Tomography of the Chest/Thorax (L34416) Local Coverage Determination (LCD): Computerized Axial Tomography of the Chest/Thorax (L34416) Links in PDF documents are not guaranteed to work. To follow a web link, please use the MCD Website. Contractor

More information

CLINICAL MEDICATION POLICY

CLINICAL MEDICATION POLICY Policy Name: Policy Number: Responsible Department(s): CLINICAL MEDICATION POLICY Granulocyte Colony Stimulating Factors (G-CSFs) MP-016-MD-DE Medical Management; Clinical Pharmacy Provider Notice Date:

More information

Growth Hormone Excluding Serostim / Zorbtive

Growth Hormone Excluding Serostim / Zorbtive Drugs Requiring Prior Authorization *RESTRICTED PHARMACY NETWORK APPLIES See Prior Authorization Forms or contact Navitus Customer Care at 1-877-908-6023 for details. Label Name GCN *GENOTROPIN 12 MG CARTRIDGE

More information

SITES (ALPHABETICAL) HPV CS SITE SPECIFIC FACTOR

SITES (ALPHABETICAL) HPV CS SITE SPECIFIC FACTOR SITES (ALPHABETICAL) HPV CS SITE SPECIFIC FACTOR Anus: Anal Canal; Anus, NOS; Other Parts of Rectum C21.0-C21.2, C21.8 C21.0 Anus, NOS (excludes skin of anus and perianal skin C44.5) C21.1 Anal canal C21.2

More information

CLINICAL MEDICATION POLICY

CLINICAL MEDICATION POLICY CLINICAL MEDICATION POLICY Policy Name: Opdivo (nivolumab) injection Policy Number: Approved By: Medical Management, Clinical Pharmacy Products: Highmark Health Options Application: All participating hospitals

More information

Intensity Modulated Radiation Therapy (IMRT)

Intensity Modulated Radiation Therapy (IMRT) Intensity Modulated Radiation Therapy (IMRT) [For the list of services and procedures that need preauthorization, please refer to www.mcs.com.pr go to Comunicados a Proveedores, and click Cartas Circulares.]

More information

Opiate Overutilization

Opiate Overutilization Texas Prior Authorization Program Clinical Edit Criteria Drug/Drug Class Clinical Edit Information Included in this Document Drugs requiring prior authorization: the list of drugs requiring prior authorization

More information

Colony Stimulating Factors: Neupogen (filgrastim), Neulasta (pegfilgrastim), Leukine (sargramostim), Granix (tbo-filgrastim)

Colony Stimulating Factors: Neupogen (filgrastim), Neulasta (pegfilgrastim), Leukine (sargramostim), Granix (tbo-filgrastim) Neupogen (filgrastim), Neulasta (sargramostim), Granix (tbo-filgrastim) Date of Origin: 10/17/2008 Dates Reviewed: 6/17/2009, 12/22/2009, 06/15/2010/ 7/20/2010, 09/2010, 12/2010, 03/2011, 06/2011, 09/2011,

More information

CEA (CARCINOEMBRYONIC ANTIGEN)

CEA (CARCINOEMBRYONIC ANTIGEN) (CARCINOEMBRYONIC ANTIGEN) 428 C15.3 Malignant neoplasm of upper third of esophagus C15.4 Malignant neoplasm of middle third of esophagus C15.5 Malignant neoplasm of lower third of esophagus C15.8 Malignant

More information

Peripheral Nerve Blocks

Peripheral Nerve Blocks Last Review Date: April 21, 2017 Number: MG.MM.ME.64v2 Medical Guideline Disclaimer Property of EmblemHealth. All rights reserved. The treating physician or primary care provider must submit to EmblemHealth

More information

Genetic Testing for Cancer Susceptibility

Genetic Testing for Cancer Susceptibility Last Review Date: March 10, 2017 Number: MG.MM.AD.17v3 Medical Guideline Disclaimer Property of EmblemHealth. All rights reserved. The treating physician or primary care provider must submit to EmblemHealth

More information

Table of Contents. Last updated by CLO: 5/8/2013 1

Table of Contents. Last updated by CLO: 5/8/2013 1 Table of Contents Drug-induced liver injury algorithm - Cases... 2 Drug-induced liver injury algorithm - Controls... 3 1. Summary of drug-induced liver injury algorithm... 4 2. Terminology... 4 3. Threshold

More information

Increlex (Mecasermin)

Increlex (Mecasermin) Texas Prior Authorization Program Clinical Edit Criteria Drug/Drug Class Clinical Edit Information Included in this Document Drugs requiring prior authorization: the list of drugs requiring prior authorization

More information

DATA REQUEST RESPONSE- XRT AND BRACHYTHERAPY

DATA REQUEST RESPONSE- XRT AND BRACHYTHERAPY Date: 10 th April 2018 DATA REQUEST RESPONSE- XRT AND BRACHYTHERAPY Request: 1. Utilization Data of Overseas Beam Therapy and Brachytherapy 2. Diagnoses Data of Overseas Claims for Beam Therapy and Brachytherapy

More information

Cancer in Estonia 2014

Cancer in Estonia 2014 Cancer in Estonia 2014 Estonian Cancer Registry (ECR) is a population-based registry that collects data on all cancer cases in Estonia. More information about ECR is available at the webpage of National

More information

Actiq (Oral Transmucosal Fentanyl)

Actiq (Oral Transmucosal Fentanyl) Texas Prior Authorization Program Clinical Edit Criteria Drug/Drug Class Actiq (Oral Transmucosal Fentanyl) Clinical Edit Information Included in this Document Actiq 200mcg Drugs requiring prior authorization:

More information

Pembrolizumab (Keytruda )

Pembrolizumab (Keytruda ) Last Review Date: March 14, 2017 Number: MG.MM.PH.10f Medical Guideline Disclaimer Property of EmblemHealth. All rights reserved. The treating physician or primary care provider must submit to EmblemHealth

More information

MALIGNANT NEOPLASMS OF THE BREAST MALIGNANT NEOPLASMS OF FEMALE GENITAL ORGANS

MALIGNANT NEOPLASMS OF THE BREAST MALIGNANT NEOPLASMS OF FEMALE GENITAL ORGANS MALIGNANT NEOPLASMS OF THE (INC. PAGET S DISEASE) 0 - Nipple and areola 1 - Central portion 2 - Upper-inner quadrant 3 - Lower-inner quadrant 4 - Upper-outer quadrant 5 - Lower-outer quadrant 6 - Axillary

More information

155.2 Malignant neoplasm of liver not specified as primary or secondary. C22.9 Malignant neoplasm of liver, not specified as primary or secondary

155.2 Malignant neoplasm of liver not specified as primary or secondary. C22.9 Malignant neoplasm of liver, not specified as primary or secondary ICD-9 TO ICD-10 Reference ICD-9 150.9 Malignant neoplasm of esophagus unspecified site C15.9 Malignant neoplasm of esophagus, unspecified 151.9 Malignant neoplasm of stomach unspecified site C16.9 Malignant

More information

Anatomical Considerations for Lab Practical II

Anatomical Considerations for Lab Practical II Anatomical Considerations for Lab Practical II For each of the following please be prepared to provide: Identification System Organ(s) or ducts to Function(s) location which it is attached Use your lecture

More information

Contractor Information. LCD Information. Local Coverage Determination (LCD): Computerized Axial Tomography (CT), Thorax (L33459) Document Information

Contractor Information. LCD Information. Local Coverage Determination (LCD): Computerized Axial Tomography (CT), Thorax (L33459) Document Information Local Coverage Determination (LCD): Computerized Axial Tomography (CT), Thorax (L33459) Links in PDF documents are not guaranteed to work. To follow a web link, please use the MCD Website. Contractor Information

More information

CLINICAL MEDICAL POLICY

CLINICAL MEDICAL POLICY Policy Name: Policy Number: Responsible Department(s): CLINICAL MEDICAL POLICY Opdivo (nivolumab) MP-004-MC-PA Medical Management; Clinical Pharmacy Provider Notice Date: 09/01/2018; 06/15/2018; 04/01/2017

More information

Duragesic (Fentanyl Transdermal)

Duragesic (Fentanyl Transdermal) Texas Prior Authorization Program Clinical Edit Criteria Drug/Drug Class Clinical Edit Information Included in this Document Drugs requiring prior authorization: the list of drugs requiring prior authorization

More information

Gamma Glutamyl Transferase

Gamma Glutamyl Transferase Other Names/Abbreviations GGT 190.32 - Gamma Glutamyl Transferase Gamma glutamyl transferase (GGT) is an intracellular enzyme that appears in blood following leakage from cells. Renal tubules, liver, and

More information

Contractor Information. LCD Information. Local Coverage Determination (LCD): CT of the Abdomen and Pelvis (L34415) Document Information

Contractor Information. LCD Information. Local Coverage Determination (LCD): CT of the Abdomen and Pelvis (L34415) Document Information Local Coverage Determination (LCD): CT of the Abdomen and Pelvis (L34415) Links in PDF documents are not guaranteed to work. To follow a web link, please use the MCD Website. Contractor Information Contractor

More information

Annual Report. Cape Cod Hospital and Falmouth Hospital Regional Cancer Network Expert physicians. Quality hospitals. Superior care.

Annual Report. Cape Cod Hospital and Falmouth Hospital Regional Cancer Network Expert physicians. Quality hospitals. Superior care. Annual Report Cape Cod Hospital and Falmouth Hospital Regional Cancer Network 2013 Expert physicians. Quality hospitals. Superior care. Cape Cod Hospital s Davenport- Mugar Hematology/Oncology Center and

More information

Crosswalk File of ICD9 Diagnosis Codes to Risk Group Assignment 1-Apr-15

Crosswalk File of ICD9 Diagnosis Codes to Risk Group Assignment 1-Apr-15 1 1500 MALIGNANT NEOPLASM OF CERVICAL ESOPHAGUS 1 1501 MALIGNANT NEOPLASM OF THORACIC ESOPHAGUS 1 1502 MALIGNANT NEOPLASM OF ABDOMINAL ESOPHAGUS 1 1503 MALIGNANT NEOPLASM OF UPPER THIRD OF ESOPHAGUS 1

More information

2011 to 2015 New Cancer Incidence Truman Medical Center - Hospital Hill

2011 to 2015 New Cancer Incidence Truman Medical Center - Hospital Hill Number of New Cancers Truman Medical Center Hospital Hill Cancer Registry 2015 Statistical Summary Incidence In 2015, Truman Medical Center diagnosed and/or treated 406 new cancer cases. Four patients

More information

S2 File. Clinical Classifications Software (CCS). The CCS is a

S2 File. Clinical Classifications Software (CCS). The CCS is a S2 File. Clinical Classifications Software (CCS). The CCS is a diagnosis categorization scheme based on the ICD-9-CM that aggregates all diagnosis codes into 262 mutually exclusive, clinically homogeneous

More information

Contractor Information. LCD Information. Local Coverage Determination (LCD): CT of the Abdomen and Pelvis (L34415) Document Information

Contractor Information. LCD Information. Local Coverage Determination (LCD): CT of the Abdomen and Pelvis (L34415) Document Information Local Coverage Determination (LCD): CT of the Abdomen and Pelvis (L34415) Links in PDF documents are not guaranteed to work. To follow a web link, please use the MCD Website. Contractor Information Contractor

More information

Group B: Organ systems (digestive, respiratory, urinary, genital system, heart, glands and skin) green

Group B: Organ systems (digestive, respiratory, urinary, genital system, heart, glands and skin) green Group B: Organ systems (digestive, respiratory, urinary, genital system, heart, glands and skin) green Digestive system 1. Teeth Main points: external and internal structure of a tooth, fixation of a tooth

More information

NEW/REVISED MATERIAL: Presented in italicized text EFFECTIVE DATE: January 1, 2008 GUIDELINES FOR REPORTING ADMINISTRATION OF EPOGEN MEDICARE

NEW/REVISED MATERIAL: Presented in italicized text EFFECTIVE DATE: January 1, 2008 GUIDELINES FOR REPORTING ADMINISTRATION OF EPOGEN MEDICARE DISCLAIMER: Please be advised that while every effort has been made to ensure the accuracy of the information provided according to the most current LCD pertaining to the subject, periodic change to rules

More information

ANNUAL CANCER REGISTRY REPORT-2005

ANNUAL CANCER REGISTRY REPORT-2005 ANNUAL CANCER REGISTRY REPORT-25 CANCER STATISTICS Distribution of neoplasms Of a total of 3,115 new neoplasms diagnosed or treated at the Hospital from January 25 to December, 25, 1,473 were seen in males

More information

Morphine Equivalent Dosing

Morphine Equivalent Dosing Texas Prior Authorization Program Clinical Criteria Drug/Drug Class This criteria was recommended for review by the Texas Medicaid Vendor Drug Program to ensure appropriate and safe utilization. Clinical

More information

Florida Cancer Data System STAT File Documentation Version 2019

Florida Cancer Data System STAT File Documentation Version 2019 Florida Cancer Data System STAT File Documentation Version 2019 Field Description NAACCR Item Recoded Patient ID Number 20 Addr at DX - State 80 X County at DX 90 Addr at DX Country 102 X Marital Status

More information

Carcinoembryonic Antigen

Carcinoembryonic Antigen Other Names/Abbreviations CEA 190.26 - Carcinoembryonic Antigen Carcinoembryonic antigen (CEA) is a protein polysaccharide found in some carcinomas. It is effective as a biochemical marker for monitoring

More information

BRAF Mutation Analysis

BRAF Mutation Analysis Last Review Date: October 13, 2017 Number: MG.MM.LA.38aC Medical Guideline Disclaimer Property of EmblemHealth. All rights reserved. The treating physician or primary care provider must submit to EmblemHealth

More information

ACTIVITY 11: RESPIRATORY AND DIGESTIVE SYSTEMS RESPIRATORY SYSTEM

ACTIVITY 11: RESPIRATORY AND DIGESTIVE SYSTEMS RESPIRATORY SYSTEM ACTIVITY 11: RESPIRATORY AND DIGESTIVE SYSTEMS OBJECTIVES: 1) How to get ready: Read Chapters 25 and 26, McKinley et al., Human Anatomy, 4e. All text references are for this textbook. 2) Identify structures

More information

Anatomy. Contents Brain (Questions)

Anatomy. Contents Brain (Questions) Anatomy 12 Contents 12.1 Brain (Questions).................................................... 683 12.2 Head and Neck (Questions)............................................. 685 12.3 Thorax (Questions)...................................................

More information

SEER Advanced Topic 2018 Presentation. EOD 2018 and SS2018 Jennifer Ruhl

SEER Advanced Topic 2018 Presentation. EOD 2018 and SS2018 Jennifer Ruhl SEER Advanced Topic 2018 Presentation EOD 2018 and SS2018 Jennifer Ruhl May 25, 2018 Outline General overview of EOD Schemas Basic review of what is needed to collect Primary Tumor, Regional Nodes and

More information

RESPIRATORY SYSTEM. described: pp. 744,746 fig. 25.1, described: p. 746 fig described: p. 776 fig. 26.3

RESPIRATORY SYSTEM. described: pp. 744,746 fig. 25.1, described: p. 746 fig described: p. 776 fig. 26.3 ACTIVITY 11: RESPIRATORY AND DIGESTIVE SYSTEMS OBJECTIVES: 1) How to get ready: Read Chapters 25 and 26, McKinley et al., Human Anatomy, 5e. All text references are for this textbook. 2) Identify structures

More information

END-SEMESTER EXAM 2018 ANATOMY, HISTOLOGY AND EMBRYOLOGY FACULTY OF MEDICINE, 2 ND SEMESTER

END-SEMESTER EXAM 2018 ANATOMY, HISTOLOGY AND EMBRYOLOGY FACULTY OF MEDICINE, 2 ND SEMESTER University of Szeged, Faculty of Medicine Department of Anatomy, Histology and Embryology Chairman: Prof. Antal Nógrádi MD, PhD, DSc Kossuth L. sgt. 40., H-6724 Szeged, Hungary Tel.: +36-62-545-665 P.

More information

Truman Medical Center-Hospital Hill Cancer Registry 2014 Statistical Summary Incidence

Truman Medical Center-Hospital Hill Cancer Registry 2014 Statistical Summary Incidence Truman Medical Center-Hospital Hill Cancer Registry 2014 Statistical Summary Incidence In 2014, there were 452 new cancer cases diagnosed and or treated at Truman Medical Center- Hospital Hill and an additional

More information

General Anatomy p. 1 Organization of the Human Body p. 1 Skeleton of the Human Body p. 4 Ossification of the Bones p. 6 Bone Structure p. 8 Joints p.

General Anatomy p. 1 Organization of the Human Body p. 1 Skeleton of the Human Body p. 4 Ossification of the Bones p. 6 Bone Structure p. 8 Joints p. General Anatomy p. 1 Organization of the Human Body p. 1 Skeleton of the Human Body p. 4 Ossification of the Bones p. 6 Bone Structure p. 8 Joints p. 10 Principal Joints (Immovable) p. 12 Synovial Joints

More information

The original MED criteria can be referenced at the Texas Vendor Drug Program website located at

The original MED criteria can be referenced at the Texas Vendor Drug Program website located at Morphine Equivalent Dosing (MED) Clinical Edit Criteria Drug/Drug Class Morphine Equivalent Dosing (MED) Superior HealthPlan follows the guidance of the Texas Vendor Drug Program (VDP) for all clinical

More information

This lab activity is aligned with Visible Body s Human Anatomy Atlas app. Learn more at visiblebody.com/professors

This lab activity is aligned with Visible Body s Human Anatomy Atlas app. Learn more at visiblebody.com/professors 1 This lab activity is aligned with Visible Body s Human Anatomy Atlas app. Learn more at visiblebody.com/professors 2 A. Digestive System Overview To Start: Go to the Views menu and scroll down to the

More information

Khapzory (levoleucovorin) (Intravenous)

Khapzory (levoleucovorin) (Intravenous) Khapzory (levoleucovorin) (Intravenous) Last Review Date: 12/04/2018 Date of Origin: 12/04/2018 Dates Reviewed: 12/2018 Document Number: IC-0408 I. Length of Authorization Coverage will be provided for

More information

APPENDIX ONE: ICD CODES

APPENDIX ONE: ICD CODES APPENDIX ONE: ICD CODES ICD-10-AM ICD-9-CM Malignant neoplasms C00 C97 140 208, 238.6, 273.3 Lip, oral cavity and pharynx C00 C14 140 149 Digestive organs C15 C26 150 157, 159 Oesophagus 4 C15 150 excluding

More information

Neoplasms/Lymphoma/Leukemia

Neoplasms/Lymphoma/Leukemia Neoplasms/Lymphoma/Leukemia Session Guidelines This is a 15 minute webinar session for CNC physicians and staff CNC holds webinars monthly to address topics related to risk adjustment documentation and

More information

Fusilev (levoleucovorin) Document Number: IC-0183

Fusilev (levoleucovorin) Document Number: IC-0183 Fusilev (levoleucovorin) Document Number: IC-0183 Last Review Date: 2/1/2018 Date of Origin: 01/02/2014 Dates Reviewed: 08/2014, 03/2015, 05/2015, 08/2015, 11/2015, 02/2016, 05/2016, 08/2016, 11/2016,

More information

incidence rate x 100,000/year

incidence rate x 100,000/year Tier R=rare C=common Cancer Entity European crude and age adjusted incidence by cancer, years of diagnosis 2000 and 2007 Analisys based on 83 population-based cancer registries * applying the European

More information

Globally Optimal Statistical Classification Models, I: Binary Class Variable, One Ordered Attribute

Globally Optimal Statistical Classification Models, I: Binary Class Variable, One Ordered Attribute Globally Optimal Statistical Classification Models, I: Binary Class Variable, One Ordered Attribute Paul R. Yarnold, Ph.D. and Robert C. Soltysik, M.S. Optimal Data Analysis, LLC Imagine a random sample

More information

Introduction to ICD-O-3 coding rules

Introduction to ICD-O-3 coding rules Introduction to ICD-O-3 coding rules Weena Laddachayaporn, MD National Cancer Institute, Bangkok, Thailand ICD-O-3 The International Classification of Diseases for Oncology Is a coding system for primary

More information

2016 Cancer Registry Annual Report

2016 Cancer Registry Annual Report 2016 Cancer Registry Annual Report Cancer Committee Chairman s Report The Cancer Committee at Cancer Treatment Centers of America (CTCA) at Eastern Regional Medical Center (Eastern), established in 2006,

More information

List of Codes Used to Identify Measures Reported in the Dialysis Facility Report for FY 2019

List of Codes Used to Identify Measures Reported in the Dialysis Facility Report for FY 2019 List of Codes Used to Identify Measures Reported in the Dialysis Facility Report for FY 2019 Table of Contents Table 4: Hospitalization Summary for Medicare Dialysis Patients... 4 SEPTICEMIA 4 MYOCARDIAL

More information

Keytruda (pembrolizumab) (Intravenous)

Keytruda (pembrolizumab) (Intravenous) Keytruda (pembrolizumab) (Intravenous) Last Review Date: 02/06/2018 Date of Origin: 09/30/2014 Document Number: IC-0209 Dates Reviewed: 9/2014, 3/2015, 5/2015, 8/2015, 10/2015, 11/2015, 2/2016, 5/2016,

More information

Lab 5 Digestion and Hormones of Digestion. 7/16/2015 MDufilho 1

Lab 5 Digestion and Hormones of Digestion. 7/16/2015 MDufilho 1 Lab 5 Digestion and Hormones of Digestion 1 Figure 23.1 Alimentary canal and related accessory digestive organs. Mouth (oral cavity) Tongue* Parotid gland Sublingual gland Submandibular gland Salivary

More information

Jhia Anjela D. Rivera 1 1. BS Biology, Department of Biology, College of Science, Polytechnic University of the Philippines

Jhia Anjela D. Rivera 1 1. BS Biology, Department of Biology, College of Science, Polytechnic University of the Philippines DIGESTIVE SYSTEM Jhia Anjela D. Rivera 1 1 BS Biology, Department of Biology, College of Science, Polytechnic University of the Philippines DIGESTIVE SYSTEM Consists of the digestive tract (gastrointestinal

More information

Lungs a. d. b. c. e.

Lungs a. d. b. c. e. Lungs d. e. Lungs Right superior lobe Right middle lobe Right inferior lobe d. Left superior lobe e. Left inferior lobe Sinuses d. Nasal Cavity & Sinuses g. g. i. Nasal Cavity & Sinuses g. h. d. f. e.

More information

2012 Cancer Report 2011 Registry Data

2012 Cancer Report 2011 Registry Data 2012 Cancer Report 2011 Registry Data Contents Goals and Objectives 1 2012 Cancer Committee Members 2 Total Cancer Cases 1981-2011 3 Cancer Registry Frequency Report 1981-2011 4-5 Cancer Registry Frequency

More information

RAMATHIBODI CANCER REPORT

RAMATHIBODI CANCER REPORT RAMATHIBODI CANCER REPORT 2016 Ramathibodi Cancer Registry : A subsidiary of Ramathibodi Comprehensive Cancer Center Faculty of Medicine, Ramathibodi Hospital Mahidol University Table of content INTRODUCTION...III

More information

Human Anatomy & Physiology. Introduction (Ch. 1)

Human Anatomy & Physiology. Introduction (Ch. 1) Human Anatomy & Physiology Introduction (Ch. 1) Overview of Anatomy and Physiology Anatomy the study of the structure of body parts and their relationships to one another Gross or macroscopic Microscopic

More information

AMBULATORY SURGERY CENTER CODING AND PAYMENT GUIDE

AMBULATORY SURGERY CENTER CODING AND PAYMENT GUIDE Targeted Drug Delivery AMBULATORY SURGERY CENTER CODING AND PAYMENT GUIDE 2018 Flowonix Medical has compiled this coding information for your convenience. This information is gathered from third party

More information

All Discovered Death Outcome Detail (Form 124/120)

All Discovered Death Outcome Detail (Form 124/120) This file includes all reported deaths regardless of consent. ID WHI Common ID Col#1 DEATHALL All Discovered Death Col#2 Any report of death, regardless of consent status. 0 No 106,931 66.1 1 Yes 54,877

More information

Descriptive Histology

Descriptive Histology Atlas of Descriptive Histology Michael H. Ross University of Florida College of Medicine Gainesville, Florida Wojciech Pawlina Mayo Medical School College of Medicine, Mayo Clinic Rochester, Minnesota

More information

OVARIES URETER FALLOPIAN TUBES BLADDER UROGENITAL OPENINGS (BOTH SEXES) PENIS VAGINA UTERUS

OVARIES URETER FALLOPIAN TUBES BLADDER UROGENITAL OPENINGS (BOTH SEXES) PENIS VAGINA UTERUS URETER OVARIES FALLOPIAN TUBES BLADDER UROGENITAL OPENINGS (BOTH SEXES) PENIS VAGINA UTERUS REPRODUCTIVE PRODUCE FEMALE HORMONES EXCRETORY FROM KIDNEY TO BLADDER EXCRETORY STORES URINE REPRODUCTIVE TRANSPORTS

More information

Fig. A.1. Frontal. plane. Transverse. plane. Sagittal plane. Copyright McGraw-Hill Education. Permission required for reproduction or display.

Fig. A.1. Frontal. plane. Transverse. plane. Sagittal plane. Copyright McGraw-Hill Education. Permission required for reproduction or display. Fig. A.1 Frontal plane Transverse plane Sagittal plane McGraw-Hill Education/Joe DeGrandis Fig. A.2 (a) Sagittal section (b) Frontal section (c) Transverse section Table A.1 Fig. A.3 Cephalic r. (head)

More information

Body Regions Review. Anatomical Position. Anatomical Planes. Supine versus Prone 9/9/2009

Body Regions Review. Anatomical Position. Anatomical Planes. Supine versus Prone 9/9/2009 Body Regions Review The fundamental divisions of the human body Christine Sparks Anatomy / Physiology I Sept. 9, 2009 Anatomical Position Universal terms are used to describe the body accurately and result

More information

*

* Introduction Cancer is complex, can have many possible causes, and is increasingly common. For the U.S. population, 1 in 2 males and 1 in 3 females is at risk of developing cancer in their lifetime. The

More information

MEDICAL POLICY Gene Expression Profiling for Cancers of Unknown Primary Site

MEDICAL POLICY Gene Expression Profiling for Cancers of Unknown Primary Site POLICY: PG0364 ORIGINAL EFFECTIVE: 04/22/16 LAST REVIEW: 07/26/18 MEDICAL POLICY Gene Expression Profiling for Cancers of Unknown Primary Site GUIDELINES This policy does not certify benefits or authorization

More information

Respiratory & Digestive Organs of the Head and Neck, Human;

Respiratory & Digestive Organs of the Head and Neck, Human; Name Date Lab Exercise 5: Lab Exercise 6: Lab Exercise 7: Lab Exercise 8: Respiratory & Digestive Organs of the Head and Neck, Human; Histology of the Respiratory System Digestive System Models, Human

More information

Digestive System. In one end and out the other.

Digestive System. In one end and out the other. Digestive System In one end and out the other. Overview Every cell in the body needs nourishment, yet most cells cannot leave their position in the body and travel to a food source, so the food must be

More information

CODING PRIMARY SITE. Nadya Dimitrova

CODING PRIMARY SITE. Nadya Dimitrova CODING PRIMARY SITE Nadya Dimitrova OUTLINE What is coding and why do we need it? ICD-10 and ICD-O ICD-O-3 Topography coding rules ICD-O-3 online WHAT IS CODING AND WHY DO WE NEED IT? Coding: to assign

More information

John R. Marsh Cancer Center

John R. Marsh Cancer Center John R. Marsh Cancer Center Lung Program Overview: 2014-2015 Initiatives Lung CT Screening Dr. Gregory Zimmerman In cooperation with The Lung Cancer Steering Committee, Diagnostic Imaging Services at the

More information

MedStar Health, Inc. POLICY AND PROCEDURE MANUAL

MedStar Health, Inc. POLICY AND PROCEDURE MANUAL MedStar Health, Inc. POLICY AND PROCEDURE MANUAL MP.138.MH Oral Maxillofacial Prosthesis This policy applies to the following lines of business: MedStar Employee (Select) MedStar MA DSNP CSNP MedStar CareFirst

More information

Section 2 - Musculo-skeletal System. A list of the first 3 digits - 72 terms

Section 2 - Musculo-skeletal System. A list of the first 3 digits - 72 terms 1 Section 2 - Musculo-skeletal System A list of the first - 72 terms Index + Regional terms 2 MUSCULOSKELETAL SYSTEM 20 Musculoskeletal system: general terms 201 Skeletal system 202 Muscular system: types

More information

Veins of the Face and the Neck

Veins of the Face and the Neck Veins of the Face and the Neck Facial Vein The facial vein is formed at the medial angle of the eye by the union of the supraorbital and supratrochlear veins. connected through the ophthalmic veins with

More information

SHN-1 Human Digestive Panel Test results

SHN-1 Human Digestive Panel Test results SHN-1 Human Digestive Panel Test results HN-30 tongue HN-24 salivary gland HN-12 larynx HN-28 esophagus HN-29 stomach HN-20 pancreas HN-13 liver HN-14 gall bladder HN-27-1 duodenum HN-27-2 ileum HN-27-3

More information

HOSPITAL-BASED CANCER REGISTRY ANNUAL REPORT 2011

HOSPITAL-BASED CANCER REGISTRY ANNUAL REPORT 2011 HOSPITAL-BASED CANCER REGISTRY ANNUAL REPORT 2011 SONGKLANAGARIND HOSPITAL FACULTY OF MEDICINE PRINCE OF SONGKLA UNIVERSITY HATYAI SONGKHLA THAILAND EDITOR PARADEE PRECHAWITTAYAKUL, B.Sc. June, 2013 Songklanagarind

More information

Chapter II: Overview

Chapter II: Overview : Overview Chapter II: Overview This chapter provides an overview of the status of cancer in Minnesota, using cases reported to the Minnesota Cancer Surveillance System (MCSS) and deaths reported to the

More information

ORGANS OF THE DIGESTIVE SYSTEM

ORGANS OF THE DIGESTIVE SYSTEM ORGANS OF THE DIGESTIVE SYSTEM OBJECTIVES: 1. List and describe the major activities of the digestive system. 2. Identify and give the functions of the organs in and along the digestive tract. MAJOR ACTIVITIES

More information

LCD for Interferon (L29202)

LCD for Interferon (L29202) LCD for Interferon (L29202) Contractor Name First Coast Service Options, Inc. Contractor Number 09102 Contractor Type MAC - Part B Contractor Information LCD ID Number L29202 LCD Information LCD Title

More information

Grade Coding Instructions and Tables

Grade Coding Instructions and Tables Grade Coding Instructions and Tables Effective with Cases Diagnosed 1/1/2018 and Forward DRAFT published April 2018 Editors: Jennifer Ruhl, MSHCA, RHIT, CCS, CTR, NCI SEER Jim Hofferkamp, CTR, NAACCR Elizabeth

More information

Links in PDF documents are not guaranteed to work. To follow a web link, please use the MCD Website.

Links in PDF documents are not guaranteed to work. To follow a web link, please use the MCD Website. Local Coverage Determination (LCD): Flow Cytometry (L34215) Links in PDF documents are not guaranteed to work. To follow a web link, please use the MCD Website. Contractor Information Contractor Name Contract

More information

Contractor Information. LCD Information. Local Coverage Determination (LCD): Flow Cytometry (L34513) Document Information

Contractor Information. LCD Information. Local Coverage Determination (LCD): Flow Cytometry (L34513) Document Information Local Coverage Determination (LCD): Flow Cytometry (L34513) Links in PDF documents are not guaranteed to work. To follow a web link, please use the MCD Website. Contractor Information Contractor Name Contract

More information

Cancer survival in Shanghai, China,

Cancer survival in Shanghai, China, Cancer survival in Shanghai, China, 1992 1995 Xiang YB, Jin F and Gao YT Abstract The Shanghai cancer registry, established in 1963, is the oldest one in mainland China; cancer registration is entirely

More information